Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-51495 | tai-screen-luciferase | 4.504 | 3.53e-22 | 1.24e-03 | 1.88e-03 | 5 | 2 |
int-snw-51741 | tai-screen-luciferase | 6.174 | 2.67e-126 | 1.32e-06 | 4.54e-03 | 24 | 19 |
reg-snw-55869 | tai-screen-luciferase | 4.752 | 5.69e-25 | 4.24e-04 | 6.99e-04 | 8 | 5 |
reg-snw-52 | tai-screen-luciferase | 4.903 | 9.49e-27 | 2.11e-04 | 3.66e-04 | 9 | 6 |
reg-snw-55854 | tai-screen-luciferase | 4.880 | 1.80e-26 | 2.35e-04 | 4.05e-04 | 5 | 3 |
reg-snw-353274 | tai-screen-luciferase | 4.583 | 4.72e-23 | 8.88e-04 | 1.38e-03 | 9 | 4 |
reg-snw-5770 | tai-screen-luciferase | 4.418 | 2.91e-21 | 1.75e-03 | 2.57e-03 | 13 | 7 |
reg-snw-10198 | tai-screen-luciferase | 4.688 | 3.15e-24 | 5.65e-04 | 9.12e-04 | 9 | 5 |
reg-snw-8450 | tai-screen-luciferase | 5.269 | 2.26e-31 | 3.26e-05 | 6.40e-05 | 5 | 2 |
reg-snw-60 | tai-screen-luciferase | 4.243 | 1.88e-19 | 3.43e-03 | 4.71e-03 | 12 | 5 |
reg-snw-4904 | tai-screen-luciferase | 5.516 | 1.01e-34 | 8.14e-06 | 1.73e-05 | 6 | 4 |
reg-snw-1964 | tai-screen-luciferase | 4.532 | 1.75e-22 | 1.10e-03 | 1.69e-03 | 7 | 6 |
reg-snw-10097 | tai-screen-luciferase | 4.851 | 3.99e-26 | 2.69e-04 | 4.60e-04 | 6 | 3 |
reg-snw-1974 | tai-screen-luciferase | 4.940 | 3.36e-27 | 1.76e-04 | 3.10e-04 | 6 | 4 |
reg-snw-1665 | tai-screen-luciferase | 4.688 | 3.16e-24 | 5.65e-04 | 9.13e-04 | 5 | 2 |
reg-snw-1432 | tai-screen-luciferase | 4.670 | 5.00e-24 | 6.11e-04 | 9.80e-04 | 9 | 5 |
reg-snw-27130 | tai-screen-luciferase | 4.707 | 1.89e-24 | 5.18e-04 | 8.42e-04 | 7 | 4 |
reg-snw-1121 | tai-screen-luciferase | 4.707 | 1.91e-24 | 5.19e-04 | 8.44e-04 | 5 | 3 |
reg-snw-988 | tai-screen-luciferase | 5.672 | 6.20e-37 | 3.20e-06 | 7.14e-06 | 5 | 3 |
reg-snw-6169 | tai-screen-luciferase | 4.851 | 3.99e-26 | 2.70e-04 | 4.60e-04 | 8 | 5 |
reg-snw-1500 | tai-screen-luciferase | 4.226 | 2.77e-19 | 3.65e-03 | 4.98e-03 | 9 | 7 |
reg-snw-821 | tai-screen-luciferase | 4.344 | 1.76e-20 | 2.34e-03 | 3.35e-03 | 11 | 4 |
reg-snw-4609 | tai-screen-luciferase | 4.325 | 2.79e-20 | 2.52e-03 | 3.58e-03 | 14 | 8 |
reg-snw-84343 | tai-screen-luciferase | 4.236 | 2.24e-19 | 3.52e-03 | 4.83e-03 | 10 | 5 |
reg-snw-51164 | tai-screen-luciferase | 4.586 | 4.41e-23 | 8.78e-04 | 1.37e-03 | 6 | 4 |
reg-snw-9967 | tai-screen-luciferase | 5.027 | 2.86e-28 | 1.15e-04 | 2.08e-04 | 8 | 6 |
reg-snw-89910 | tai-screen-luciferase | 4.386 | 6.32e-21 | 1.98e-03 | 2.88e-03 | 6 | 4 |
reg-snw-57120 | tai-screen-luciferase | 4.450 | 1.33e-21 | 1.54e-03 | 2.29e-03 | 12 | 6 |
Gene Symbol | Entrez Gene ID | Frequency | tai-screen-luciferase gene score | Best subnetwork score | Degree | List-Gonzales GI | Tai-Hits |
---|---|---|---|---|---|---|---|
MAPK8 | 5599 | 28 | -4.403 | 6.468 | 153 | - | - |
COPA | 1314 | 48 | -9.395 | 5.672 | 340 | Yes | Yes |
PAFAH1B1 | 5048 | 18 | -2.583 | 4.586 | 55 | Yes | - |
CTSF | 8722 | 8 | -3.978 | 4.236 | 1 | - | Yes |
IQGAP1 | 8826 | 2 | -3.777 | 4.851 | 10 | - | - |
TNFRSF8 | 943 | 19 | -4.106 | 4.450 | 15 | - | - |
EIF1AX | 1964 | 14 | -3.005 | 4.532 | 43 | Yes | - |
CUL4B | 8450 | 21 | -2.809 | 5.269 | 142 | - | - |
HSF1 | 3297 | 46 | -4.179 | 5.027 | 209 | - | Yes |
ARFGEF1 | 10565 | 13 | -2.722 | 4.344 | 15 | - | - |
CANX | 821 | 17 | -1.959 | 4.504 | 65 | - | - |
MAPK14 | 1432 | 5 | 2.079 | 4.670 | 32 | - | - |
INVS | 27130 | 3 | 1.950 | 4.707 | 29 | - | - |
ZC3H15 | 55854 | 14 | 3.269 | 4.880 | 11 | - | - |
RPS16 | 6217 | 38 | -5.444 | 4.880 | 205 | - | - |
CDC42 | 998 | 44 | -6.960 | 4.707 | 276 | Yes | Yes |
UTP18 | 51096 | 8 | -1.709 | 4.236 | 106 | - | - |
SIVA1 | 10572 | 5 | -3.759 | 5.027 | 89 | - | Yes |
NME2 | 4831 | 24 | -3.034 | 4.325 | 53 | - | - |
RPS6 | 6194 | 44 | -5.603 | 8.046 | 217 | Yes | - |
TLK2 | 11011 | 21 | -4.011 | 5.672 | 14 | - | - |
ACTR2 | 10097 | 2 | -2.490 | 4.851 | 65 | Yes | - |
RAN | 5901 | 38 | -3.809 | 4.325 | 258 | Yes | Yes |
COPB1 | 1315 | 39 | -6.221 | 9.063 | 118 | Yes | Yes |
RPS13 | 6207 | 43 | -6.589 | 7.555 | 174 | Yes | - |
CDC5L | 988 | 34 | -3.419 | 5.672 | 155 | - | - |
SRPK2 | 6733 | 10 | -2.827 | 4.940 | 109 | - | - |
OR1J2 | 26740 | 3 | -3.429 | 4.386 | 12 | - | - |
ZNF672 | 79894 | 5 | -2.681 | 4.670 | 98 | - | - |
THAP11 | 57215 | 9 | -3.673 | 4.325 | 3 | - | Yes |
GOPC | 57120 | 19 | 1.749 | 4.450 | 68 | - | - |
RPL38 | 6169 | 6 | -1.992 | 4.851 | 4 | Yes | - |
HDAC8 | 55869 | 6 | 1.228 | 4.752 | 16 | - | - |
ODC1 | 4953 | 9 | -2.503 | 4.325 | 12 | - | - |
RPS9 | 6203 | 45 | -7.127 | 7.555 | 140 | Yes | - |
DHX15 | 1665 | 2 | -1.795 | 4.688 | 37 | - | - |
PES1 | 23481 | 16 | 2.917 | 4.226 | 91 | - | - |
RPS4X | 6191 | 44 | -6.747 | 7.555 | 263 | Yes | - |
DNAJC10 | 54431 | 13 | -2.349 | 4.344 | 11 | - | - |
YEATS4 | 8089 | 14 | -4.444 | 4.532 | 18 | Yes | Yes |
COPZ1 | 22818 | 48 | -8.301 | 9.063 | 13 | Yes | Yes |
BRCA2 | 675 | 8 | -1.991 | 4.236 | 111 | - | - |
WDR46 | 9277 | 31 | -4.290 | 4.226 | 101 | Yes | Yes |
RPS27A | 6233 | 45 | -5.631 | 8.389 | 344 | Yes | - |
PSMD3 | 5709 | 22 | -3.935 | 6.408 | 201 | - | Yes |
RPS14 | 6208 | 23 | -4.803 | 7.011 | 204 | Yes | - |
PSMD8 | 5714 | 15 | -2.916 | 4.418 | 143 | - | - |
PTPLAD1 | 51495 | 2 | 0.875 | 4.504 | 8 | - | - |
ACP1 | 52 | 8 | -2.230 | 4.903 | 46 | - | - |
SRF | 6722 | 15 | 1.994 | 4.243 | 23 | - | - |
CTNND1 | 1500 | 16 | -2.651 | 4.226 | 53 | Yes | - |
ACTB | 60 | 15 | -1.716 | 4.243 | 23 | - | - |
RPS26 | 6231 | 43 | -7.478 | 8.046 | 60 | Yes | - |
ZNF445 | 353274 | 6 | 1.629 | 4.583 | 3 | - | - |
RPS2 | 6187 | 16 | -3.241 | 4.226 | 13 | Yes | - |
DMD | 1756 | 15 | -4.338 | 4.243 | 53 | - | - |
RNF20 | 56254 | 28 | -4.564 | 6.174 | 18 | - | - |
THRAP3 | 9967 | 5 | 2.507 | 5.027 | 22 | - | - |
SPDL1 | 54908 | 3 | -3.376 | 4.707 | 31 | Yes | Yes |
SRC | 6714 | 28 | -2.806 | 6.174 | 419 | Yes | - |
COPB2 | 9276 | 48 | -13.168 | 9.063 | 41 | Yes | Yes |
CKAP5 | 9793 | 46 | -7.214 | 5.672 | 130 | Yes | Yes |
RB1 | 5925 | 21 | -2.085 | 4.707 | 351 | - | - |
PTPN1 | 5770 | 10 | 2.067 | 4.418 | 1 | - | - |
EIF2S2 | 8894 | 31 | -4.320 | 5.672 | 103 | Yes | - |
CHM | 1121 | 13 | -0.483 | 4.707 | 2 | - | - |
MYC | 4609 | 9 | -1.920 | 4.325 | 77 | - | - |
RPS11 | 6205 | 44 | -6.588 | 7.555 | 175 | Yes | - |
DCTN4 | 51164 | 13 | -1.882 | 4.586 | 19 | - | - |
MRPS12 | 6183 | 35 | -5.421 | 5.516 | 341 | Yes | - |
GCN1L1 | 10985 | 10 | -2.918 | 4.418 | 43 | - | - |
YBX1 | 4904 | 24 | -3.033 | 5.516 | 296 | - | - |
UBE3B | 89910 | 3 | -1.312 | 4.386 | 6 | - | - |
UBB | 7314 | 30 | -4.289 | 6.428 | 147 | - | - |
MPHOSPH9 | 10198 | 5 | 2.055 | 4.688 | 41 | - | - |
SERBP1 | 26135 | 35 | -4.612 | 5.516 | 106 | - | Yes |
HES4 | 57801 | 19 | -4.153 | 4.450 | 10 | - | - |
HPS3 | 84343 | 8 | -1.516 | 4.236 | 41 | - | - |
PRIM2 | 5558 | 6 | -3.507 | 5.269 | 67 | - | - |
CAPRIN1 | 4076 | 14 | -2.226 | 4.688 | 42 | - | - |
WDR18 | 57418 | 6 | 2.322 | 4.752 | 213 | - | - |
EIF4A2 | 1974 | 4 | -2.084 | 4.940 | 35 | Yes | - |
RPS24 | 6229 | 46 | -7.034 | 8.389 | 217 | Yes | - |
TCERG1 | 10915 | 28 | -3.808 | 6.174 | 58 | Yes | - |
ZNF286A | 57335 | 2 | 3.076 | 4.504 | 116 | - | - |
RPS15A | 6210 | 36 | -5.413 | 7.555 | 177 | Yes | - |
WWOX | 51741 | 28 | -2.448 | 6.174 | 38 | - | - |
EIF2S3 | 1968 | 14 | -3.144 | 4.532 | 13 | Yes | - |
RPS19 | 6223 | 21 | -4.701 | 4.752 | 102 | Yes | - |
EIF3M | 10480 | 18 | 4.451 | 4.880 | 55 | Yes | - |
UACA | 55075 | 5 | -2.177 | 4.688 | 76 | - | - |
NFKBIB | 4793 | 28 | -3.978 | 6.174 | 78 | - | - |
ARCN1 | 372 | 48 | -8.232 | 9.063 | 118 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
CDC42 | 998 | RPS27A | 6233 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
MYC | 4609 | RPS16 | 6217 | pp | -- | int.Intact: MI:0914(association); int.I2D: AGRAVAL_MYC |
TNFRSF8 | 943 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
RPS4X | 6191 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | HDAC8 | 55869 | pd | > | reg.ITFP.txt: no annot |
NME2 | 4831 | RPS19 | 6223 | pp | -- | int.Proteinpedia: Mass spectrometry |
MRPS12 | 6183 | THRAP3 | 9967 | pd | > | reg.ITFP.txt: no annot |
ACP1 | 52 | WDR18 | 57418 | pd | < | reg.ITFP.txt: no annot |
ARCN1 | 372 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA, YeastMedium, INTEROLOG |
EIF2S2 | 8894 | PES1 | 23481 | pp | -- | int.I2D: YeastLow |
PAFAH1B1 | 5048 | ARFGEF1 | 10565 | pd | > | reg.ITFP.txt: no annot |
MYC | 4609 | PSMD3 | 5709 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct, KOCH_MYC |
ACTB | 60 | RPS4X | 6191 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPS11 | 6205 | RPS19 | 6223 | pp | -- | int.I2D: IntAct_Yeast |
RPS11 | 6205 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | CANX | 821 | pd | < | reg.ITFP.txt: no annot |
COPA | 1314 | RB1 | 5925 | pd | <> | reg.ITFP.txt: no annot |
TCERG1 | 10915 | WWOX | 51741 | pp | -- | int.I2D: BioGrid, MINT, Pawson1; int.Mint: MI:0915(physical association) |
HSF1 | 3297 | SRF | 6722 | pd | <> | reg.ITFP.txt: no annot |
HSF1 | 3297 | SRF | 6722 | pp | -- | int.Yu: muscle |
MAPK14 | 1432 | RB1 | 5925 | pp | -- | int.Intact: MI:0217(phosphorylation reaction); int.I2D: MINT; int.Mint: MI:0217(phosphorylation reaction) |
CUL4B | 8450 | INVS | 27130 | pd | <> | reg.ITFP.txt: no annot |
COPA | 1314 | PSMD8 | 5714 | pp | -- | int.I2D: YeastLow |
RPS6 | 6194 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
MRPS12 | 6183 | SIVA1 | 10572 | pd | <> | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS14 | 6208 | pp | -- | int.I2D: INTEROLOG, YeastMedium, BioGrid_Yeast |
CDC5L | 988 | CUL4B | 8450 | pd | <> | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS4X | 6191 | pp | -- | int.I2D: YeastHigh, YeastMedium, INTEROLOG |
RPS11 | 6205 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
WDR46 | 9277 | UTP18 | 51096 | pp | -- | int.I2D: YeastLow |
CDC5L | 988 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS14 | 6208 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
ARFGEF1 | 10565 | GCN1L1 | 10985 | pp | -- | int.I2D: YeastHigh |
SRC | 6714 | CKAP5 | 9793 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACTB | 60 | RPS9 | 6203 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPS6 | 6194 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
RAN | 5901 | WDR18 | 57418 | pd | < | reg.ITFP.txt: no annot |
ARCN1 | 372 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
RB1 | 5925 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
CANX | 821 | ARFGEF1 | 10565 | pd | > | reg.ITFP.txt: no annot |
EIF2S3 | 1968 | ACTR2 | 10097 | pp | -- | int.I2D: YeastLow |
HSF1 | 3297 | ZNF672 | 79894 | pd | <> | reg.ITFP.txt: no annot |
YBX1 | 4904 | RPS11 | 6205 | pp | -- | int.Intact: MI:0914(association) |
CANX | 821 | CAPRIN1 | 4076 | pd | > | reg.ITFP.txt: no annot |
MYC | 4609 | COPB2 | 9276 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct |
CDC42 | 998 | UBB | 7314 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
HDAC8 | 55869 | WDR18 | 57418 | pd | < | reg.ITFP.txt: no annot |
NFKBIB | 4793 | UBB | 7314 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
MAPK14 | 1432 | YEATS4 | 8089 | pp | -- | int.I2D: BioGrid_Yeast |
RB1 | 5925 | HES4 | 57801 | pd | > | reg.pazar.txt: no annot |
RPS9 | 6203 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RPS13 | 6207 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
SRPK2 | 6733 | ACTR2 | 10097 | pp | -- | int.I2D: BioGrid_Yeast |
MYC | 4609 | UBB | 7314 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vivo |
PAFAH1B1 | 5048 | UBE3B | 89910 | pd | > | reg.ITFP.txt: no annot |
RPS27A | 6233 | GCN1L1 | 10985 | pp | -- | int.I2D: YeastLow |
EIF1AX | 1964 | RPS11 | 6205 | pp | -- | int.I2D: YeastMedium |
RPS4X | 6191 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
CHM | 1121 | PRIM2 | 5558 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ARCN1 | 372 | MYC | 4609 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACP1 | 52 | MRPS12 | 6183 | pd | < | reg.ITFP.txt: no annot |
CHM | 1121 | COPA | 1314 | pd | < | reg.ITFP.txt: no annot |
YBX1 | 4904 | SERBP1 | 26135 | pd | > | reg.ITFP.txt: no annot |
RPS9 | 6203 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
EIF1AX | 1964 | EIF2S3 | 1968 | pd | > | reg.ITFP.txt: no annot |
DHX15 | 1665 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
MYC | 4609 | ODC1 | 4953 | pd | > | reg.TRANSFAC.txt: no annot |
ACTB | 60 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | MYC | 4609 | pp | -- | int.I2D: BioGrid |
NME2 | 4831 | RPS16 | 6217 | pp | -- | int.Proteinpedia: Mass spectrometry |
ACTB | 60 | RPS19 | 6223 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RB1 | 5925 | SERBP1 | 26135 | pd | > | reg.pazar.txt: no annot |
RPS9 | 6203 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | MRPS12 | 6183 | pp | -- | int.I2D: BioGrid_Yeast |
YBX1 | 4904 | RPS4X | 6191 | pp | -- | int.Intact: MI:0914(association) |
YBX1 | 4904 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
MRPS12 | 6183 | RPS2 | 6187 | pp | -- | int.I2D: YeastMedium |
CDC5L | 988 | ZNF445 | 353274 | pd | <> | reg.ITFP.txt: no annot |
PES1 | 23481 | UBE3B | 89910 | pp | -- | int.I2D: YeastLow |
RPS11 | 6205 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
UACA | 55075 | ZNF672 | 79894 | pd | <> | reg.ITFP.txt: no annot |
RPS27A | 6233 | ACTR2 | 10097 | pp | -- | int.I2D: YeastLow |
RB1 | 5925 | ACTR2 | 10097 | pd | > | reg.ITFP.txt: no annot |
ACTB | 60 | RPS24 | 6229 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
UTP18 | 51096 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
CDC5L | 988 | MAPK14 | 1432 | pd | > | reg.ITFP.txt: no annot |
RAN | 5901 | RPS11 | 6205 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, MINT_Worm, NON_CORE |
CKAP5 | 9793 | HDAC8 | 55869 | pd | > | reg.ITFP.txt: no annot |
RPS13 | 6207 | WDR46 | 9277 | pp | -- | int.I2D: BioGrid_Yeast |
CTNND1 | 1500 | SRC | 6714 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vitro, in vivo |
RPS14 | 6208 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
EIF1AX | 1964 | RPS15A | 6210 | pp | -- | int.I2D: YeastMedium |
MAPK14 | 1432 | YBX1 | 4904 | pd | < | reg.ITFP.txt: no annot |
RPS4X | 6191 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | MAPK14 | 1432 | pp | -- | int.I2D: CORE_2 |
SIVA1 | 10572 | WDR18 | 57418 | pd | <> | reg.ITFP.txt: no annot |
MYC | 4609 | YBX1 | 4904 | pd | > | reg.TRANSFAC.txt: no annot |
MYC | 4609 | YBX1 | 4904 | pp | -- | int.Intact: MI:0914(association); int.I2D: AGRAVAL_MYC |
SRC | 6714 | SRF | 6722 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vitro |
ACTR2 | 10097 | UTP18 | 51096 | pd | < | reg.ITFP.txt: no annot |
RPS27A | 6233 | ARFGEF1 | 10565 | pp | -- | int.I2D: YeastLow |
SRPK2 | 6733 | CUL4B | 8450 | pd | < | reg.ITFP.txt: no annot |
HSF1 | 3297 | UACA | 55075 | pd | <> | reg.ITFP.txt: no annot |
BRCA2 | 675 | ACTR2 | 10097 | pd | > | reg.ITFP.txt: no annot |
EIF4A2 | 1974 | SERBP1 | 26135 | pd | > | reg.ITFP.txt: no annot |
RPS9 | 6203 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
CKAP5 | 9793 | SPDL1 | 54908 | pd | > | reg.ITFP.txt: no annot |
RPS6 | 6194 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
MPHOSPH9 | 10198 | UACA | 55075 | pd | < | reg.ITFP.txt: no annot |
COPA | 1314 | MAPK14 | 1432 | pd | > | reg.ITFP.txt: no annot |
COPA | 1314 | MAPK14 | 1432 | pp | -- | int.I2D: BioGrid_Yeast |
MRPS12 | 6183 | WDR18 | 57418 | pd | <> | reg.ITFP.txt: no annot |
CUL4B | 8450 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
EIF4A2 | 1974 | PRIM2 | 5558 | pd | > | reg.ITFP.txt: no annot |
RPS2 | 6187 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
DHX15 | 1665 | RPS4X | 6191 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
UBB | 7314 | WWOX | 51741 | pp | -- | int.I2D: BCI, HPRD; int.HPRD: in vivo |
PAFAH1B1 | 5048 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
PAFAH1B1 | 5048 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
EIF1AX | 1964 | RPS2 | 6187 | pp | -- | int.I2D: YeastMedium |
UBB | 7314 | RNF20 | 56254 | pp | -- | int.Intact: MI:0220(ubiquitination reaction); int.I2D: IntAct |
CAPRIN1 | 4076 | CKAP5 | 9793 | pd | < | reg.ITFP.txt: no annot |
YBX1 | 4904 | PTPN1 | 5770 | pd | > | reg.TRANSFAC.txt: no annot |
RPS2 | 6187 | RPS9 | 6203 | pp | -- | int.I2D: BIND_Yeast |
RPS15A | 6210 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS24 | 6229 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | YBX1 | 4904 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPS11 | 6205 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | EIF3M | 10480 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
CTNND1 | 1500 | MYC | 4609 | pp | -- | int.Intact: MI:0914(association); int.I2D: AGRAVAL_MYC |
YBX1 | 4904 | GCN1L1 | 10985 | pd | <> | reg.ITFP.txt: no annot |
CKAP5 | 9793 | PTPLAD1 | 51495 | pd | > | reg.ITFP.txt: no annot |
CDC42 | 998 | ARFGEF1 | 10565 | pp | -- | int.I2D: IntAct, SOURAV_MAPK_LOW |
COPA | 1314 | ACTR2 | 10097 | pd | > | reg.ITFP.txt: no annot |
PSMD3 | 5709 | UTP18 | 51096 | pp | -- | int.I2D: IntAct_Yeast |
MYC | 4609 | RB1 | 5925 | pp | -- | int.I2D: BCI, HPRD, BioGrid; int.Transfac: -; int.Ravasi: -; int.HPRD: in vivo |
MYC | 4609 | RAN | 5901 | pd | > | reg.ITFP.txt: no annot |
RPS2 | 6187 | EIF3M | 10480 | pd | < | reg.ITFP.txt: no annot |
NFKBIB | 4793 | IQGAP1 | 8826 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
SRC | 6714 | WWOX | 51741 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
RPS16 | 6217 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
DHX15 | 1665 | CAPRIN1 | 4076 | pd | > | reg.ITFP.txt: no annot |
MYC | 4609 | IQGAP1 | 8826 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct |
EIF4A2 | 1974 | EIF3M | 10480 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, IntAct |
MAPK14 | 1432 | HSF1 | 3297 | pd | < | reg.ITFP.txt: no annot |
DHX15 | 1665 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
CTNND1 | 1500 | PES1 | 23481 | pd | <> | reg.ITFP.txt: no annot |
RPS13 | 6207 | RPS19 | 6223 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
MAPK14 | 1432 | MAPK8 | 5599 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
RPS27A | 6233 | UBB | 7314 | pp | -- | int.I2D: BIND |
PSMD3 | 5709 | PSMD8 | 5714 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, IntAct_Yeast, INTEROLOG, Krogan_Core, YeastHigh |
MYC | 4609 | THAP11 | 57215 | pd | < | reg.TRANSFAC.txt: no annot |
IQGAP1 | 8826 | ACTR2 | 10097 | pd | > | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
EIF1AX | 1964 | YEATS4 | 8089 | pd | > | reg.ITFP.txt: no annot |
YBX1 | 4904 | PSMD8 | 5714 | pd | > | reg.ITFP.txt: no annot |
RAN | 5901 | GCN1L1 | 10985 | pp | -- | int.I2D: YeastLow |
EIF1AX | 1964 | RPS9 | 6203 | pp | -- | int.I2D: YeastMedium |
CUL4B | 8450 | ACTR2 | 10097 | pd | > | reg.ITFP.txt: no annot |
ACP1 | 52 | EIF1AX | 1964 | pp | -- | int.I2D: YeastMedium |
RPS4X | 6191 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium, INTEROLOG |
ACTB | 60 | COPA | 1314 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | COPA | 1314 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | UBB | 7314 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
CAPRIN1 | 4076 | CUL4B | 8450 | pd | < | reg.ITFP.txt: no annot |
RPS6 | 6194 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RAN | 5901 | RPS2 | 6187 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, CORE_2, MINT_Worm |
COPA | 1314 | COPB1 | 1315 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct_Yeast, MINT_Yeast, Krogan_Core, YeastHigh |
PSMD8 | 5714 | MRPS12 | 6183 | pd | < | reg.ITFP.txt: no annot |
CDC5L | 988 | MPHOSPH9 | 10198 | pd | > | reg.ITFP.txt: no annot |
CDC5L | 988 | CKAP5 | 9793 | pd | <> | reg.ITFP.txt: no annot |
PSMD3 | 5709 | ACTR2 | 10097 | pp | -- | int.I2D: YeastLow |
DHX15 | 1665 | RPS13 | 6207 | pp | -- | int.I2D: IntAct_Yeast, BioGrid_Yeast |
RPS16 | 6217 | EIF3M | 10480 | pd | < | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMD8 | 5714 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | DHX15 | 1665 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast |
RAN | 5901 | WDR46 | 9277 | pp | -- | int.I2D: YeastLow |
PAFAH1B1 | 5048 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
DMD | 1756 | SRF | 6722 | pd | < | reg.pazar.txt: no annot; reg.TRANSFAC.txt: no annot |
CANX | 821 | RB1 | 5925 | pd | <> | reg.ITFP.txt: no annot |
CANX | 821 | PSMD3 | 5709 | pp | -- | int.I2D: IntAct_Yeast |
MPHOSPH9 | 10198 | UTP18 | 51096 | pd | < | reg.ITFP.txt: no annot |
BRCA2 | 675 | CTSF | 8722 | pd | > | reg.ITFP.txt: no annot |
RPS14 | 6208 | UTP18 | 51096 | pd | < | reg.ITFP.txt: no annot |
ACP1 | 52 | CDC5L | 988 | pd | < | reg.ITFP.txt: no annot |
YBX1 | 4904 | RPS24 | 6229 | pp | -- | int.Intact: MI:0914(association) |
MYC | 4609 | MAPK8 | 5599 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vitro, in vivo |
WDR46 | 9277 | PES1 | 23481 | pd | <> | reg.ITFP.txt: no annot |
HSF1 | 3297 | MAPK8 | 5599 | pp | -- | int.I2D: HPRD, INNATEDB; int.HPRD: in vitro, in vivo |
PSMD8 | 5714 | ACTR2 | 10097 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | ACTR2 | 10097 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast |
ACTB | 60 | RAN | 5901 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, NON_CORE |
EIF4A2 | 1974 | SRPK2 | 6733 | pd | > | reg.ITFP.txt: no annot |
DHX15 | 1665 | UTP18 | 51096 | pp | -- | int.I2D: YeastLow |
MAPK14 | 1432 | ZNF672 | 79894 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | PAFAH1B1 | 5048 | pp | -- | int.I2D: BioGrid_Yeast |
HSF1 | 3297 | OR1J2 | 26740 | pd | > | reg.ITFP.txt: no annot |
COPA | 1314 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastMedium |
RPS19 | 6223 | INVS | 27130 | pd | < | reg.ITFP.txt: no annot |
CANX | 821 | MRPS12 | 6183 | pp | -- | int.I2D: BioGrid_Yeast |
PES1 | 23481 | WDR18 | 57418 | pd | <> | reg.ITFP.txt: no annot |
ACTB | 60 | EIF1AX | 1964 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
CANX | 821 | PTPLAD1 | 51495 | pd | > | reg.ITFP.txt: no annot |
CDC42 | 998 | GOPC | 57120 | pp | -- | int.I2D: BioGrid |
DHX15 | 1665 | RAN | 5901 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
COPA | 1314 | SRPK2 | 6733 | pd | > | reg.ITFP.txt: no annot |
COPB1 | 1315 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastMedium; int.DIP: MI:0915(physical association) |
EIF2S3 | 1968 | PSMD3 | 5709 | pp | -- | int.I2D: YeastLow |
CANX | 821 | COPA | 1314 | pd | <> | reg.ITFP.txt: no annot |
THRAP3 | 9967 | SIVA1 | 10572 | pd | < | reg.ITFP.txt: no annot |
COPA | 1314 | CAPRIN1 | 4076 | pd | > | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS11 | 6205 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
NME2 | 4831 | RPL38 | 6169 | pp | -- | int.Proteinpedia: Mass spectrometry |
INVS | 27130 | SPDL1 | 54908 | pd | > | reg.ITFP.txt: no annot |
ACTB | 60 | ARCN1 | 372 | pp | -- | int.I2D: BioGrid_Yeast |
MYC | 4609 | NME2 | 4831 | pd | < | reg.TRANSFAC.txt: no annot |
RPS6 | 6194 | EIF3M | 10480 | pd | < | reg.ITFP.txt: no annot |
DHX15 | 1665 | RPS19 | 6223 | pp | -- | int.I2D: IntAct_Yeast |
PTPN1 | 5770 | SRC | 6714 | pp | -- | int.I2D: MINT, BCI, HPRD, INNATEDB; int.Mint: MI:0915(physical association), MI:0217(phosphorylation reaction), MI:0203(dephosphorylation reaction), MI:0914(association); int.HPRD: in vitro, in vivo |
RPS4X | 6191 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
EIF1AX | 1964 | EIF2S2 | 8894 | pp | -- | int.I2D: BioGrid_Yeast |
MYC | 4609 | GCN1L1 | 10985 | pp | -- | int.Intact: MI:0914(association), MI:0915(physical association); int.I2D: BioGrid, IntAct, KOCH_MYC, SOURAV_MAPK_HIGH |
RPS15A | 6210 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | TLK2 | 11011 | pd | > | reg.ITFP.txt: no annot |
EIF1AX | 1964 | RPS14 | 6208 | pp | -- | int.I2D: YeastMedium |
DHX15 | 1665 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RPS13 | 6207 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
CUL4B | 8450 | DNAJC10 | 54431 | pd | > | reg.ITFP.txt: no annot |
ACTB | 60 | YEATS4 | 8089 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RPS13 | 6207 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
HSF1 | 3297 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
RPS19 | 6223 | WDR18 | 57418 | pd | < | reg.ITFP.txt: no annot |
DHX15 | 1665 | PES1 | 23481 | pp | -- | int.I2D: YeastLow |
CDC5L | 988 | YBX1 | 4904 | pd | <> | reg.ITFP.txt: no annot |
MRPS12 | 6183 | HDAC8 | 55869 | pd | > | reg.ITFP.txt: no annot |
YBX1 | 4904 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
DHX15 | 1665 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
DHX15 | 1665 | WDR46 | 9277 | pp | -- | int.I2D: YeastLow |
BRCA2 | 675 | PRIM2 | 5558 | pd | > | reg.ITFP.txt: no annot |
RB1 | 5925 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS15A | 6210 | pp | -- | int.I2D: INTEROLOG, YeastMedium, BIND_Yeast |
COPA | 1314 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
CDC5L | 988 | GCN1L1 | 10985 | pp | -- | int.I2D: BioGrid |
CDC5L | 988 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
CTNND1 | 1500 | RPS2 | 6187 | pd | > | reg.ITFP.txt: no annot |
EIF1AX | 1964 | RPS16 | 6217 | pp | -- | int.I2D: YeastMedium |
RPS11 | 6205 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS2 | 6187 | RPS16 | 6217 | pp | -- | int.I2D: INTEROLOG, YeastMedium, BioGrid_Yeast |
CDC5L | 988 | COPA | 1314 | pd | <> | reg.ITFP.txt: no annot |
COPA | 1314 | CUL4B | 8450 | pd | <> | reg.ITFP.txt: no annot |
CDC5L | 988 | EIF2S2 | 8894 | pd | > | reg.ITFP.txt: no annot |
HSF1 | 3297 | UBE3B | 89910 | pd | > | reg.ITFP.txt: no annot |
COPB1 | 1315 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid |
CHM | 1121 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
RPS13 | 6207 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
DHX15 | 1665 | MYC | 4609 | pp | -- | int.Proteinpedia: Tandem Affinity Purification; int.I2D: BioGrid, IntAct, KOCH_MYC |
CKAP5 | 9793 | MPHOSPH9 | 10198 | pd | > | reg.ITFP.txt: no annot |
ACTB | 60 | EIF4A2 | 1974 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ARCN1 | 372 | COPB1 | 1315 | pp | -- | int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, BIND, BIND_Yeast, HPRD, Krogan_Core, MIPS; int.HPRD: in vivo |
BRCA2 | 675 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS9 | 6203 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
EIF2S3 | 1968 | GCN1L1 | 10985 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | GCN1L1 | 10985 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
CANX | 821 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
PTPLAD1 | 51495 | ZNF286A | 57335 | pd | < | reg.ITFP.txt: no annot |
CDC42 | 998 | IQGAP1 | 8826 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, HPRD, MINT, BCI, IntAct; int.Mint: MI:0915(physical association), MI:0407(direct interaction); int.HPRD: in vitro, in vivo |
ACTB | 60 | SRC | 6714 | pp | -- | int.I2D: MINT |
EIF4A2 | 1974 | CKAP5 | 9793 | pd | <> | reg.ITFP.txt: no annot |
ARCN1 | 372 | COPA | 1314 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, HPRD, Krogan_Core; int.HPRD: in vivo |
EIF2S3 | 1968 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
EIF1AX | 1964 | EIF3M | 10480 | pd | <> | reg.ITFP.txt: no annot |
CDC42 | 998 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
CANX | 821 | DNAJC10 | 54431 | pd | > | reg.ITFP.txt: no annot |
CDC5L | 988 | RPL38 | 6169 | pd | > | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
EIF3M | 10480 | ZC3H15 | 55854 | pd | > | reg.ITFP.txt: no annot |
CDC5L | 988 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid |
COPA | 1314 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
MAPK8 | 5599 | WWOX | 51741 | pp | -- | int.I2D: MINT, HPRD; int.Mint: MI:0915(physical association); int.HPRD: in vivo, yeast 2-hybrid |
COPA | 1314 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS16 | 6217 | RPS26 | 6231 | pp | -- | int.I2D: BioGrid_Yeast |
COPB1 | 1315 | ARFGEF1 | 10565 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15A | 6210 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
ARCN1 | 372 | COPB2 | 9276 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
ACTB | 60 | SRF | 6722 | pd | < | reg.pazar.txt: no annot; reg.oreganno.txt: no annot |
CDC5L | 988 | ACTR2 | 10097 | pd | > | reg.ITFP.txt: no annot |
MAPK14 | 1432 | SRPK2 | 6733 | pp | -- | int.I2D: BioGrid_Yeast |
RAN | 5901 | PES1 | 23481 | pd | < | reg.ITFP.txt: no annot |
MYC | 4609 | RPS2 | 6187 | pp | -- | int.Intact: MI:0914(association); int.I2D: AGRAVAL_MYC |
EIF2S3 | 1968 | EIF2S2 | 8894 | pp | -- | int.Intact: MI:0407(direct interaction); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, YeastHigh, Yu_GoldStd |
CDC5L | 988 | THRAP3 | 9967 | pd | > | reg.ITFP.txt: no annot |
PRIM2 | 5558 | CUL4B | 8450 | pd | < | reg.ITFP.txt: no annot |
PSMD3 | 5709 | GCN1L1 | 10985 | pd | <> | reg.ITFP.txt: no annot |
COPB1 | 1315 | MAPK14 | 1432 | pp | -- | int.I2D: IntAct_Mouse, MINT_Mouse |
RPS6 | 6194 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
RPS24 | 6229 | RPS27A | 6233 | pp | -- | int.I2D: YeastMedium |
RPS27A | 6233 | EIF3M | 10480 | pd | < | reg.ITFP.txt: no annot |
PSMD3 | 5709 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
COPA | 1314 | PAFAH1B1 | 5048 | pd | <> | reg.ITFP.txt: no annot |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0006413 | translational initiation | 6.96e-22 | 1.14e-17 | 4.670 | 19 | 27 | 131 |
GO:0022627 | cytosolic small ribosomal subunit | 2.01e-20 | 3.28e-16 | 5.870 | 13 | 21 | 39 |
GO:0006412 | translation | 2.73e-18 | 4.45e-14 | 3.901 | 20 | 29 | 235 |
GO:0019058 | viral life cycle | 3.05e-18 | 4.98e-14 | 4.610 | 16 | 25 | 115 |
GO:0019083 | viral transcription | 1.84e-17 | 3.00e-13 | 4.923 | 14 | 22 | 81 |
GO:0016071 | mRNA metabolic process | 2.05e-17 | 3.34e-13 | 3.902 | 19 | 29 | 223 |
GO:0044822 | poly(A) RNA binding | 2.92e-17 | 4.77e-13 | 2.469 | 34 | 42 | 1078 |
GO:0006415 | translational termination | 5.31e-17 | 8.66e-13 | 4.820 | 14 | 22 | 87 |
GO:0016070 | RNA metabolic process | 1.39e-16 | 2.27e-12 | 3.755 | 19 | 29 | 247 |
GO:0006414 | translational elongation | 1.42e-16 | 2.31e-12 | 4.723 | 14 | 22 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7.22e-16 | 1.18e-11 | 4.562 | 14 | 22 | 104 |
GO:0005829 | cytosol | 8.39e-16 | 1.37e-11 | 1.717 | 48 | 74 | 2562 |
GO:0003735 | structural constituent of ribosome | 2.30e-15 | 3.75e-11 | 4.223 | 15 | 24 | 141 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.71e-15 | 4.43e-11 | 4.430 | 14 | 22 | 114 |
GO:0016032 | viral process | 2.43e-14 | 3.97e-10 | 2.902 | 23 | 37 | 540 |
GO:0010467 | gene expression | 2.90e-14 | 4.73e-10 | 2.713 | 25 | 36 | 669 |
GO:0015935 | small ribosomal subunit | 2.88e-12 | 4.70e-08 | 6.175 | 7 | 9 | 17 |
GO:0044267 | cellular protein metabolic process | 4.06e-12 | 6.62e-08 | 2.826 | 20 | 29 | 495 |
GO:0016020 | membrane | 3.68e-11 | 6.00e-07 | 1.773 | 34 | 48 | 1746 |
GO:0005925 | focal adhesion | 2.54e-09 | 4.14e-05 | 2.831 | 15 | 23 | 370 |
GO:0048205 | COPI coating of Golgi vesicle | 6.69e-09 | 1.09e-04 | 6.077 | 5 | 6 | 13 |
GO:0030126 | COPI vesicle coat | 6.69e-09 | 1.09e-04 | 6.077 | 5 | 6 | 13 |
GO:0005515 | protein binding | 3.63e-08 | 5.93e-04 | 0.805 | 61 | 87 | 6127 |
GO:0070062 | extracellular vesicular exosome | 3.99e-08 | 6.50e-04 | 1.328 | 36 | 51 | 2516 |
GO:0005840 | ribosome | 4.16e-08 | 6.79e-04 | 4.380 | 7 | 10 | 59 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.31e-07 | 2.15e-03 | 5.318 | 5 | 5 | 22 |
GO:0005737 | cytoplasm | 1.33e-07 | 2.18e-03 | 1.022 | 46 | 65 | 3976 |
GO:0061024 | membrane organization | 1.45e-07 | 2.37e-03 | 3.435 | 9 | 11 | 146 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.62e-07 | 4.27e-03 | 5.133 | 5 | 6 | 25 |
GO:0042274 | ribosomal small subunit biogenesis | 4.72e-07 | 7.71e-03 | 5.870 | 4 | 6 | 12 |
GO:0005730 | nucleolus | 5.25e-06 | 8.57e-02 | 1.381 | 25 | 36 | 1684 |
GO:0000028 | ribosomal small subunit assembly | 6.17e-06 | 1.01e-01 | 6.233 | 3 | 3 | 7 |
GO:0003743 | translation initiation factor activity | 8.43e-06 | 1.38e-01 | 4.163 | 5 | 5 | 49 |
GO:0008135 | translation factor activity, nucleic acid binding | 9.62e-06 | 1.57e-01 | 4.870 | 4 | 4 | 24 |
GO:0005634 | nucleus | 1.71e-05 | 2.80e-01 | 0.773 | 47 | 66 | 4828 |
GO:0006364 | rRNA processing | 1.79e-05 | 2.91e-01 | 3.455 | 6 | 8 | 96 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.36e-05 | 3.84e-01 | 3.034 | 7 | 11 | 150 |
GO:0051219 | phosphoprotein binding | 3.14e-05 | 5.13e-01 | 4.455 | 4 | 4 | 32 |
GO:0034146 | toll-like receptor 5 signaling pathway | 3.40e-05 | 5.55e-01 | 3.755 | 5 | 5 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 3.40e-05 | 5.55e-01 | 3.755 | 5 | 5 | 65 |
GO:0005654 | nucleoplasm | 3.92e-05 | 6.40e-01 | 1.528 | 18 | 26 | 1095 |
GO:0034332 | adherens junction organization | 5.06e-05 | 8.26e-01 | 4.285 | 4 | 4 | 36 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 5.22e-05 | 8.51e-01 | 3.627 | 5 | 5 | 71 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 5.22e-05 | 8.51e-01 | 3.627 | 5 | 5 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 5.58e-05 | 9.11e-01 | 3.607 | 5 | 5 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 5.96e-05 | 9.73e-01 | 3.587 | 5 | 5 | 73 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 7.24e-05 | 1.00e+00 | 3.529 | 5 | 5 | 76 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 8.20e-05 | 1.00e+00 | 3.492 | 5 | 5 | 78 |
GO:0000278 | mitotic cell cycle | 8.85e-05 | 1.00e+00 | 2.141 | 10 | 16 | 398 |
GO:0034138 | toll-like receptor 3 signaling pathway | 9.25e-05 | 1.00e+00 | 3.455 | 5 | 5 | 80 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 9.25e-05 | 1.00e+00 | 3.455 | 5 | 5 | 80 |
GO:0042176 | regulation of protein catabolic process | 9.51e-05 | 1.00e+00 | 5.040 | 3 | 4 | 16 |
GO:0075733 | intracellular transport of virus | 1.15e-04 | 1.00e+00 | 4.953 | 3 | 3 | 17 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.15e-04 | 1.00e+00 | 4.953 | 3 | 3 | 17 |
GO:0071922 | regulation of cohesin localization to chromatin | 1.91e-04 | 1.00e+00 | 6.455 | 2 | 2 | 4 |
GO:0030490 | maturation of SSU-rRNA | 1.91e-04 | 1.00e+00 | 6.455 | 2 | 2 | 4 |
GO:0007000 | nucleolus organization | 1.91e-04 | 1.00e+00 | 6.455 | 2 | 2 | 4 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.98e-04 | 1.00e+00 | 3.223 | 5 | 7 | 94 |
GO:0034142 | toll-like receptor 4 signaling pathway | 2.19e-04 | 1.00e+00 | 3.192 | 5 | 5 | 96 |
GO:0051403 | stress-activated MAPK cascade | 2.51e-04 | 1.00e+00 | 3.700 | 4 | 4 | 54 |
GO:0043234 | protein complex | 3.12e-04 | 1.00e+00 | 2.226 | 8 | 9 | 300 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.18e-04 | 1.00e+00 | 6.133 | 2 | 3 | 5 |
GO:0033119 | negative regulation of RNA splicing | 3.18e-04 | 1.00e+00 | 6.133 | 2 | 2 | 5 |
GO:0002224 | toll-like receptor signaling pathway | 3.95e-04 | 1.00e+00 | 3.009 | 5 | 5 | 109 |
GO:0006417 | regulation of translation | 4.55e-04 | 1.00e+00 | 3.478 | 4 | 4 | 63 |
GO:0019843 | rRNA binding | 4.74e-04 | 1.00e+00 | 4.285 | 3 | 4 | 27 |
GO:0045182 | translation regulator activity | 4.75e-04 | 1.00e+00 | 5.870 | 2 | 2 | 6 |
GO:0006924 | activation-induced cell death of T cells | 4.75e-04 | 1.00e+00 | 5.870 | 2 | 2 | 6 |
GO:0019901 | protein kinase binding | 4.80e-04 | 1.00e+00 | 2.133 | 8 | 9 | 320 |
GO:0030529 | ribonucleoprotein complex | 4.85e-04 | 1.00e+00 | 2.944 | 5 | 8 | 114 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.13e-04 | 1.00e+00 | 3.433 | 4 | 6 | 65 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 5.13e-04 | 1.00e+00 | 3.433 | 4 | 6 | 65 |
GO:0000209 | protein polyubiquitination | 5.25e-04 | 1.00e+00 | 2.919 | 5 | 7 | 116 |
GO:0018105 | peptidyl-serine phosphorylation | 6.44e-04 | 1.00e+00 | 3.347 | 4 | 5 | 69 |
GO:0007097 | nuclear migration | 6.62e-04 | 1.00e+00 | 5.648 | 2 | 2 | 7 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.80e-04 | 1.00e+00 | 3.326 | 4 | 8 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 7.96e-04 | 1.00e+00 | 3.265 | 4 | 6 | 73 |
GO:0043066 | negative regulation of apoptotic process | 8.05e-04 | 1.00e+00 | 1.867 | 9 | 14 | 433 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 8.38e-04 | 1.00e+00 | 3.246 | 4 | 8 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 9.73e-04 | 1.00e+00 | 3.188 | 4 | 6 | 77 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 9.73e-04 | 1.00e+00 | 3.188 | 4 | 4 | 77 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.07e-03 | 1.00e+00 | 3.152 | 4 | 8 | 79 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.12e-03 | 1.00e+00 | 3.870 | 3 | 3 | 36 |
GO:0090136 | epithelial cell-cell adhesion | 1.13e-03 | 1.00e+00 | 5.285 | 2 | 2 | 9 |
GO:0021766 | hippocampus development | 1.41e-03 | 1.00e+00 | 3.755 | 3 | 3 | 39 |
GO:0030521 | androgen receptor signaling pathway | 1.63e-03 | 1.00e+00 | 3.683 | 3 | 3 | 41 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 1.63e-03 | 1.00e+00 | 3.683 | 3 | 4 | 41 |
GO:0042981 | regulation of apoptotic process | 1.71e-03 | 1.00e+00 | 2.539 | 5 | 7 | 151 |
GO:2000573 | positive regulation of DNA biosynthetic process | 1.71e-03 | 1.00e+00 | 4.996 | 2 | 2 | 11 |
GO:0005200 | structural constituent of cytoskeleton | 1.96e-03 | 1.00e+00 | 2.916 | 4 | 6 | 93 |
GO:0005838 | proteasome regulatory particle | 2.04e-03 | 1.00e+00 | 4.870 | 2 | 3 | 12 |
GO:0051146 | striated muscle cell differentiation | 2.04e-03 | 1.00e+00 | 4.870 | 2 | 2 | 12 |
GO:0043149 | stress fiber assembly | 2.04e-03 | 1.00e+00 | 4.870 | 2 | 2 | 12 |
GO:0019082 | viral protein processing | 2.04e-03 | 1.00e+00 | 4.870 | 2 | 2 | 12 |
GO:0032479 | regulation of type I interferon production | 2.41e-03 | 1.00e+00 | 4.755 | 2 | 2 | 13 |
GO:0071398 | cellular response to fatty acid | 2.41e-03 | 1.00e+00 | 4.755 | 2 | 2 | 13 |
GO:0003713 | transcription coactivator activity | 2.44e-03 | 1.00e+00 | 2.139 | 6 | 6 | 239 |
GO:0045087 | innate immune response | 2.64e-03 | 1.00e+00 | 1.510 | 10 | 11 | 616 |
GO:0035267 | NuA4 histone acetyltransferase complex | 2.80e-03 | 1.00e+00 | 4.648 | 2 | 2 | 14 |
GO:0006521 | regulation of cellular amino acid metabolic process | 2.89e-03 | 1.00e+00 | 3.396 | 3 | 5 | 50 |
GO:0007254 | JNK cascade | 3.06e-03 | 1.00e+00 | 3.368 | 3 | 3 | 51 |
GO:0006886 | intracellular protein transport | 3.10e-03 | 1.00e+00 | 2.343 | 5 | 6 | 173 |
GO:0042307 | positive regulation of protein import into nucleus | 3.21e-03 | 1.00e+00 | 4.548 | 2 | 2 | 15 |
GO:0048821 | erythrocyte development | 3.21e-03 | 1.00e+00 | 4.548 | 2 | 2 | 15 |
GO:0031369 | translation initiation factor binding | 3.21e-03 | 1.00e+00 | 4.548 | 2 | 2 | 15 |
GO:0000132 | establishment of mitotic spindle orientation | 3.66e-03 | 1.00e+00 | 4.455 | 2 | 2 | 16 |
GO:0050998 | nitric-oxide synthase binding | 3.66e-03 | 1.00e+00 | 4.455 | 2 | 3 | 16 |
GO:0019068 | virion assembly | 4.13e-03 | 1.00e+00 | 4.368 | 2 | 2 | 17 |
GO:0022624 | proteasome accessory complex | 4.13e-03 | 1.00e+00 | 4.368 | 2 | 4 | 17 |
GO:0003723 | RNA binding | 4.15e-03 | 1.00e+00 | 1.791 | 7 | 10 | 355 |
GO:0017022 | myosin binding | 4.63e-03 | 1.00e+00 | 4.285 | 2 | 2 | 18 |
GO:0043015 | gamma-tubulin binding | 4.63e-03 | 1.00e+00 | 4.285 | 2 | 2 | 18 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 4.72e-03 | 1.00e+00 | 2.200 | 5 | 5 | 191 |
GO:0043065 | positive regulation of apoptotic process | 4.78e-03 | 1.00e+00 | 1.942 | 6 | 6 | 274 |
GO:0032481 | positive regulation of type I interferon production | 5.08e-03 | 1.00e+00 | 3.110 | 3 | 3 | 61 |
GO:0017134 | fibroblast growth factor binding | 5.16e-03 | 1.00e+00 | 4.207 | 2 | 2 | 19 |
GO:2001286 | regulation of caveolin-mediated endocytosis | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0030038 | contractile actin filament bundle assembly | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0090284 | positive regulation of protein glycosylation in Golgi | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0035063 | nuclear speck organization | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0002183 | cytoplasmic translational initiation | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0004586 | ornithine decarboxylase activity | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0004673 | protein histidine kinase activity | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0034463 | 90S preribosome assembly | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0022605 | oogenesis stage | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0043004 | cytoplasmic sequestering of CFTR protein | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0018106 | peptidyl-histidine phosphorylation | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0005175 | CD27 receptor binding | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0038066 | p38MAPK cascade | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0033387 | putrescine biosynthetic process from ornithine | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0051660 | establishment of centrosome localization | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0034975 | protein folding in endoplasmic reticulum | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0046016 | positive regulation of transcription by glucose | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0000235 | astral microtubule | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0071393 | cellular response to progesterone stimulus | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0033291 | eukaryotic 80S initiation complex | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:1990264 | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0033593 | BRCA2-MAGE-D1 complex | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0046469 | platelet activating factor metabolic process | 5.70e-03 | 1.00e+00 | 7.455 | 1 | 1 | 1 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 5.71e-03 | 1.00e+00 | 4.133 | 2 | 2 | 20 |
GO:0043473 | pigmentation | 5.71e-03 | 1.00e+00 | 4.133 | 2 | 2 | 20 |
GO:0005689 | U12-type spliceosomal complex | 6.29e-03 | 1.00e+00 | 4.063 | 2 | 2 | 21 |
GO:0009306 | protein secretion | 6.29e-03 | 1.00e+00 | 4.063 | 2 | 2 | 21 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.50e-03 | 1.00e+00 | 2.433 | 4 | 4 | 130 |
GO:0045893 | positive regulation of transcription, DNA-templated | 6.59e-03 | 1.00e+00 | 1.528 | 8 | 8 | 487 |
GO:0009615 | response to virus | 6.85e-03 | 1.00e+00 | 2.411 | 4 | 4 | 132 |
GO:0007220 | Notch receptor processing | 6.89e-03 | 1.00e+00 | 3.996 | 2 | 2 | 22 |
GO:0003697 | single-stranded DNA binding | 7.15e-03 | 1.00e+00 | 2.932 | 3 | 4 | 69 |
GO:0045787 | positive regulation of cell cycle | 7.52e-03 | 1.00e+00 | 3.932 | 2 | 2 | 23 |
GO:0006351 | transcription, DNA-templated | 7.70e-03 | 1.00e+00 | 0.912 | 17 | 17 | 1585 |
GO:0000086 | G2/M transition of mitotic cell cycle | 7.80e-03 | 1.00e+00 | 2.357 | 4 | 6 | 137 |
GO:0007163 | establishment or maintenance of cell polarity | 8.17e-03 | 1.00e+00 | 3.870 | 2 | 2 | 24 |
GO:0003729 | mRNA binding | 8.35e-03 | 1.00e+00 | 2.850 | 3 | 3 | 73 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 8.85e-03 | 1.00e+00 | 3.811 | 2 | 2 | 25 |
GO:0005844 | polysome | 8.85e-03 | 1.00e+00 | 3.811 | 2 | 2 | 25 |
GO:0007265 | Ras protein signal transduction | 9.00e-03 | 1.00e+00 | 2.811 | 3 | 3 | 75 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 9.55e-03 | 1.00e+00 | 3.755 | 2 | 2 | 26 |
GO:0045931 | positive regulation of mitotic cell cycle | 9.55e-03 | 1.00e+00 | 3.755 | 2 | 2 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 9.55e-03 | 1.00e+00 | 3.755 | 2 | 2 | 26 |
GO:0005978 | glycogen biosynthetic process | 9.55e-03 | 1.00e+00 | 3.755 | 2 | 2 | 26 |
GO:0019221 | cytokine-mediated signaling pathway | 1.01e-02 | 1.00e+00 | 1.932 | 5 | 5 | 230 |
GO:0051149 | positive regulation of muscle cell differentiation | 1.03e-02 | 1.00e+00 | 3.700 | 2 | 2 | 27 |
GO:0007067 | mitotic nuclear division | 1.03e-02 | 1.00e+00 | 1.925 | 5 | 7 | 231 |
GO:0043967 | histone H4 acetylation | 1.10e-02 | 1.00e+00 | 3.648 | 2 | 2 | 28 |
GO:0071222 | cellular response to lipopolysaccharide | 1.11e-02 | 1.00e+00 | 2.700 | 3 | 4 | 81 |
GO:0071987 | WD40-repeat domain binding | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0036035 | osteoclast development | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:1990077 | primosome complex | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 2 | 2 |
GO:0044346 | fibroblast apoptotic process | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0033206 | meiotic cytokinesis | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0035305 | negative regulation of dephosphorylation | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0001672 | regulation of chromatin assembly or disassembly | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0010256 | endomembrane system organization | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0014819 | regulation of skeletal muscle contraction | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0086001 | cardiac muscle cell action potential | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0051081 | nuclear envelope disassembly | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0016344 | meiotic chromosome movement towards spindle pole | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0010632 | regulation of epithelial cell migration | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0031134 | sister chromatid biorientation | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0060265 | positive regulation of respiratory burst involved in inflammatory response | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0010736 | serum response element binding | 1.14e-02 | 1.00e+00 | 6.455 | 1 | 1 | 2 |
GO:0031252 | cell leading edge | 1.18e-02 | 1.00e+00 | 3.597 | 2 | 3 | 29 |
GO:0010332 | response to gamma radiation | 1.18e-02 | 1.00e+00 | 3.597 | 2 | 2 | 29 |
GO:0010494 | cytoplasmic stress granule | 1.26e-02 | 1.00e+00 | 3.548 | 2 | 2 | 30 |
GO:0046875 | ephrin receptor binding | 1.26e-02 | 1.00e+00 | 3.548 | 2 | 2 | 30 |
GO:0005813 | centrosome | 1.29e-02 | 1.00e+00 | 1.635 | 6 | 9 | 339 |
GO:0008134 | transcription factor binding | 1.33e-02 | 1.00e+00 | 1.835 | 5 | 5 | 246 |
GO:0007093 | mitotic cell cycle checkpoint | 1.34e-02 | 1.00e+00 | 3.501 | 2 | 2 | 31 |
GO:0043005 | neuron projection | 1.35e-02 | 1.00e+00 | 2.124 | 4 | 6 | 161 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.39e-02 | 1.00e+00 | 2.581 | 3 | 3 | 88 |
GO:0032480 | negative regulation of type I interferon production | 1.43e-02 | 1.00e+00 | 3.455 | 2 | 2 | 32 |
GO:0000187 | activation of MAPK activity | 1.47e-02 | 1.00e+00 | 2.548 | 3 | 3 | 90 |
GO:0005158 | insulin receptor binding | 1.51e-02 | 1.00e+00 | 3.411 | 2 | 2 | 33 |
GO:0000922 | spindle pole | 1.52e-02 | 1.00e+00 | 2.532 | 3 | 5 | 91 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.56e-02 | 1.00e+00 | 2.517 | 3 | 3 | 92 |
GO:0006928 | cellular component movement | 1.56e-02 | 1.00e+00 | 2.517 | 3 | 4 | 92 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.56e-02 | 1.00e+00 | 2.063 | 4 | 4 | 168 |
GO:0042692 | muscle cell differentiation | 1.60e-02 | 1.00e+00 | 3.368 | 2 | 2 | 34 |
GO:0030424 | axon | 1.68e-02 | 1.00e+00 | 2.029 | 4 | 4 | 172 |
GO:0071333 | cellular response to glucose stimulus | 1.69e-02 | 1.00e+00 | 3.326 | 2 | 2 | 35 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.70e-02 | 1.00e+00 | 1.114 | 10 | 11 | 811 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0048318 | axial mesoderm development | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0090045 | positive regulation of deacetylase activity | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0035033 | histone deacetylase regulator activity | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:2000017 | positive regulation of determination of dorsal identity | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0010484 | H3 histone acetyltransferase activity | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:1901385 | regulation of voltage-gated calcium channel activity | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0071008 | U2-type post-mRNA release spliceosomal complex | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0045505 | dynein intermediate chain binding | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0051683 | establishment of Golgi localization | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 2 | 3 |
GO:0008356 | asymmetric cell division | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0031084 | BLOC-2 complex | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0033561 | regulation of water loss via skin | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0034663 | endoplasmic reticulum chaperone complex | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0021540 | corpus callosum morphogenesis | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0030687 | preribosome, large subunit precursor | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0043293 | apoptosome | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0032204 | regulation of telomere maintenance | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:1900222 | negative regulation of beta-amyloid clearance | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0097443 | sorting endosome | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0070545 | PeBoW complex | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0051653 | spindle localization | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0033146 | regulation of intracellular estrogen receptor signaling pathway | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0090400 | stress-induced premature senescence | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0000056 | ribosomal small subunit export from nucleus | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 2 | 3 |
GO:0004705 | JUN kinase activity | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 2 | 3 |
GO:0030478 | actin cap | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 1 | 3 |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.78e-02 | 1.00e+00 | 3.285 | 2 | 2 | 36 |
GO:0006446 | regulation of translational initiation | 1.78e-02 | 1.00e+00 | 3.285 | 2 | 2 | 36 |
GO:0030426 | growth cone | 1.80e-02 | 1.00e+00 | 2.440 | 3 | 3 | 97 |
GO:0071456 | cellular response to hypoxia | 1.85e-02 | 1.00e+00 | 2.426 | 3 | 3 | 98 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.91e-02 | 1.00e+00 | 1.253 | 8 | 9 | 589 |
GO:0030218 | erythrocyte differentiation | 1.98e-02 | 1.00e+00 | 3.207 | 2 | 2 | 38 |
GO:0050681 | androgen receptor binding | 1.98e-02 | 1.00e+00 | 3.207 | 2 | 2 | 38 |
GO:0097191 | extrinsic apoptotic signaling pathway | 1.98e-02 | 1.00e+00 | 3.207 | 2 | 3 | 38 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.99e-02 | 1.00e+00 | 1.684 | 5 | 5 | 273 |
GO:0008026 | ATP-dependent helicase activity | 2.08e-02 | 1.00e+00 | 3.170 | 2 | 2 | 39 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.10e-02 | 1.00e+00 | 1.932 | 4 | 5 | 184 |
GO:0034191 | apolipoprotein A-I receptor binding | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0048478 | replication fork protection | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0015036 | disulfide oxidoreductase activity | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0072384 | organelle transport along microtubule | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 2 | 4 |
GO:0003896 | DNA primase activity | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 2 | 4 |
GO:0007258 | JUN phosphorylation | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0031577 | spindle checkpoint | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0031063 | regulation of histone deacetylation | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0010735 | positive regulation of transcription via serum response element binding | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0005968 | Rab-protein geranylgeranyltransferase complex | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0045656 | negative regulation of monocyte differentiation | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0033625 | positive regulation of integrin activation | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0009991 | response to extracellular stimulus | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0010669 | epithelial structure maintenance | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0032463 | negative regulation of protein homooligomerization | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0051902 | negative regulation of mitochondrial depolarization | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0031062 | positive regulation of histone methylation | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0070851 | growth factor receptor binding | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0016013 | syntrophin complex | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 2 | 4 |
GO:0090231 | regulation of spindle checkpoint | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0033503 | HULC complex | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0045682 | regulation of epidermis development | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0043515 | kinetochore binding | 2.26e-02 | 1.00e+00 | 5.455 | 1 | 1 | 4 |
GO:0014069 | postsynaptic density | 2.27e-02 | 1.00e+00 | 2.312 | 3 | 3 | 106 |
GO:0043547 | positive regulation of GTPase activity | 2.33e-02 | 1.00e+00 | 1.885 | 4 | 4 | 190 |
GO:0005096 | GTPase activator activity | 2.38e-02 | 1.00e+00 | 2.285 | 3 | 3 | 108 |
GO:0019899 | enzyme binding | 2.44e-02 | 1.00e+00 | 1.607 | 5 | 5 | 288 |
GO:0030496 | midbody | 2.44e-02 | 1.00e+00 | 2.272 | 3 | 4 | 109 |
GO:0008284 | positive regulation of cell proliferation | 2.45e-02 | 1.00e+00 | 1.426 | 6 | 7 | 392 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.49e-02 | 1.00e+00 | 3.029 | 2 | 2 | 43 |
GO:0034613 | cellular protein localization | 2.60e-02 | 1.00e+00 | 2.996 | 2 | 2 | 44 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.66e-02 | 1.00e+00 | 1.078 | 9 | 9 | 748 |
GO:0009411 | response to UV | 2.71e-02 | 1.00e+00 | 2.963 | 2 | 2 | 45 |
GO:1990138 | neuron projection extension | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:2000641 | regulation of early endosome to late endosome transport | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0036336 | dendritic cell migration | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0051782 | negative regulation of cell division | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0006269 | DNA replication, synthesis of RNA primer | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 2 | 5 |
GO:0097300 | programmed necrotic cell death | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0035912 | dorsal aorta morphogenesis | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0060971 | embryonic heart tube left/right pattern formation | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0016482 | cytoplasmic transport | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0051385 | response to mineralocorticoid | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0044233 | ER-mitochondrion membrane contact site | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0043043 | peptide biosynthetic process | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0051525 | NFAT protein binding | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:1901741 | positive regulation of myoblast fusion | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0071803 | positive regulation of podosome assembly | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0004663 | Rab geranylgeranyltransferase activity | 2.82e-02 | 1.00e+00 | 5.133 | 1 | 1 | 5 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.83e-02 | 1.00e+00 | 2.932 | 2 | 2 | 46 |
GO:0021762 | substantia nigra development | 2.83e-02 | 1.00e+00 | 2.932 | 2 | 2 | 46 |
GO:0016328 | lateral plasma membrane | 2.83e-02 | 1.00e+00 | 2.932 | 2 | 3 | 46 |
GO:0097190 | apoptotic signaling pathway | 2.86e-02 | 1.00e+00 | 2.182 | 3 | 3 | 116 |
GO:0008344 | adult locomotory behavior | 2.94e-02 | 1.00e+00 | 2.901 | 2 | 2 | 47 |
GO:0030168 | platelet activation | 2.97e-02 | 1.00e+00 | 1.776 | 4 | 4 | 205 |
GO:0048471 | perinuclear region of cytoplasm | 2.97e-02 | 1.00e+00 | 1.232 | 7 | 9 | 523 |
GO:0006006 | glucose metabolic process | 3.05e-02 | 1.00e+00 | 2.145 | 3 | 4 | 119 |
GO:0035690 | cellular response to drug | 3.30e-02 | 1.00e+00 | 2.811 | 2 | 3 | 50 |
GO:0007030 | Golgi organization | 3.30e-02 | 1.00e+00 | 2.811 | 2 | 3 | 50 |
GO:0043353 | enucleate erythrocyte differentiation | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0007143 | female meiotic division | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0051150 | regulation of smooth muscle cell differentiation | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0045056 | transcytosis | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0060789 | hair follicle placode formation | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0008090 | retrograde axon cargo transport | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0006333 | chromatin assembly or disassembly | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0001667 | ameboidal-type cell migration | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0000974 | Prp19 complex | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0044458 | motile cilium assembly | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0018344 | protein geranylgeranylation | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0051347 | positive regulation of transferase activity | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0010485 | H4 histone acetyltransferase activity | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0019215 | intermediate filament binding | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 2 | 6 |
GO:0034452 | dynactin binding | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0072015 | glomerular visceral epithelial cell development | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 6 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 3.46e-02 | 1.00e+00 | 2.074 | 3 | 3 | 125 |
GO:0007219 | Notch signaling pathway | 3.46e-02 | 1.00e+00 | 2.074 | 3 | 4 | 125 |
GO:0030175 | filopodium | 3.67e-02 | 1.00e+00 | 2.727 | 2 | 2 | 53 |
GO:0050679 | positive regulation of epithelial cell proliferation | 3.80e-02 | 1.00e+00 | 2.700 | 2 | 2 | 54 |
GO:0030666 | endocytic vesicle membrane | 3.80e-02 | 1.00e+00 | 2.700 | 2 | 2 | 54 |
GO:0046983 | protein dimerization activity | 3.89e-02 | 1.00e+00 | 2.007 | 3 | 3 | 131 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0006893 | Golgi to plasma membrane transport | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0097193 | intrinsic apoptotic signaling pathway | 3.92e-02 | 1.00e+00 | 2.674 | 2 | 2 | 55 |
GO:0060136 | embryonic process involved in female pregnancy | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0050658 | RNA transport | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0034101 | erythrocyte homeostasis | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0005885 | Arp2/3 protein complex | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0002162 | dystroglycan binding | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0017145 | stem cell division | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0000930 | gamma-tubulin complex | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0010447 | response to acidic pH | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0060055 | angiogenesis involved in wound healing | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0043497 | regulation of protein heterodimerization activity | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0048027 | mRNA 5'-UTR binding | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0003334 | keratinocyte development | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0070914 | UV-damage excision repair | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0010907 | positive regulation of glucose metabolic process | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0030157 | pancreatic juice secretion | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0034259 | negative regulation of Rho GTPase activity | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 1 | 7 |
GO:0000502 | proteasome complex | 4.32e-02 | 1.00e+00 | 2.597 | 2 | 4 | 58 |
GO:0016197 | endosomal transport | 4.32e-02 | 1.00e+00 | 2.597 | 2 | 3 | 58 |
GO:0008380 | RNA splicing | 4.36e-02 | 1.00e+00 | 1.597 | 4 | 5 | 232 |
GO:0045216 | cell-cell junction organization | 4.46e-02 | 1.00e+00 | 2.573 | 2 | 2 | 59 |
GO:0090009 | primitive streak formation | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0031512 | motile primary cilium | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0043589 | skin morphogenesis | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0007289 | spermatid nucleus differentiation | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0005869 | dynactin complex | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0045124 | regulation of bone resorption | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0033523 | histone H2B ubiquitination | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0003993 | acid phosphatase activity | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0010831 | positive regulation of myotube differentiation | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0006183 | GTP biosynthetic process | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0036057 | slit diaphragm | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0043114 | regulation of vascular permeability | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0034501 | protein localization to kinetochore | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0051489 | regulation of filopodium assembly | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0007172 | signal complex assembly | 4.47e-02 | 1.00e+00 | 4.455 | 1 | 1 | 8 |
GO:0010976 | positive regulation of neuron projection development | 4.59e-02 | 1.00e+00 | 2.548 | 2 | 2 | 60 |
GO:0016055 | Wnt signaling pathway | 4.67e-02 | 1.00e+00 | 1.901 | 3 | 3 | 141 |
GO:0000983 | RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0071732 | cellular response to nitric oxide | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0014075 | response to amine | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0005915 | zonula adherens | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0047497 | mitochondrion transport along microtubule | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0032319 | regulation of Rho GTPase activity | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0032495 | response to muramyl dipeptide | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0016281 | eukaryotic translation initiation factor 4F complex | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0097284 | hepatocyte apoptotic process | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0000940 | condensed chromosome outer kinetochore | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0000075 | cell cycle checkpoint | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0006241 | CTP biosynthetic process | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0021895 | cerebral cortex neuron differentiation | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0006228 | UTP biosynthetic process | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0030837 | negative regulation of actin filament polymerization | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0045059 | positive thymic T cell selection | 5.01e-02 | 1.00e+00 | 4.285 | 1 | 1 | 9 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 5.16e-02 | 1.00e+00 | 2.455 | 2 | 2 | 64 |
GO:0010628 | positive regulation of gene expression | 5.34e-02 | 1.00e+00 | 1.821 | 3 | 4 | 149 |
GO:0005882 | intermediate filament | 5.45e-02 | 1.00e+00 | 2.411 | 2 | 3 | 66 |
GO:0071260 | cellular response to mechanical stimulus | 5.45e-02 | 1.00e+00 | 2.411 | 2 | 3 | 66 |
GO:0034237 | protein kinase A regulatory subunit binding | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0001817 | regulation of cytokine production | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0051787 | misfolded protein binding | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0005798 | Golgi-associated vesicle | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0006996 | organelle organization | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0022407 | regulation of cell-cell adhesion | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0001076 | RNA polymerase II transcription factor binding transcription factor activity | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0060047 | heart contraction | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0045618 | positive regulation of keratinocyte differentiation | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0003724 | RNA helicase activity | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0010225 | response to UV-C | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 2 | 10 |
GO:0090303 | positive regulation of wound healing | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0061029 | eyelid development in camera-type eye | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0001675 | acrosome assembly | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0060218 | hematopoietic stem cell differentiation | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 5.56e-02 | 1.00e+00 | 4.133 | 1 | 1 | 10 |
GO:0030141 | secretory granule | 5.59e-02 | 1.00e+00 | 2.389 | 2 | 2 | 67 |
GO:0031295 | T cell costimulation | 5.59e-02 | 1.00e+00 | 2.389 | 2 | 3 | 67 |
GO:0043025 | neuronal cell body | 5.72e-02 | 1.00e+00 | 1.467 | 4 | 5 | 254 |
GO:0006338 | chromatin remodeling | 5.74e-02 | 1.00e+00 | 2.368 | 2 | 2 | 68 |
GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0045176 | apical protein localization | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0051895 | negative regulation of focal adhesion assembly | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0019395 | fatty acid oxidation | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0035518 | histone H2A monoubiquitination | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 2 | 11 |
GO:0021819 | layer formation in cerebral cortex | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0045502 | dynein binding | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0017166 | vinculin binding | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0042551 | neuron maturation | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0051272 | positive regulation of cellular component movement | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0045663 | positive regulation of myoblast differentiation | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0060065 | uterus development | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0004707 | MAP kinase activity | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0010390 | histone monoubiquitination | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0002011 | morphogenesis of an epithelial sheet | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 11 |
GO:0034329 | cell junction assembly | 6.20e-02 | 1.00e+00 | 2.306 | 2 | 2 | 71 |
GO:0001503 | ossification | 6.20e-02 | 1.00e+00 | 2.306 | 2 | 2 | 71 |
GO:0005198 | structural molecule activity | 6.24e-02 | 1.00e+00 | 1.727 | 3 | 5 | 159 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 6.24e-02 | 1.00e+00 | 1.727 | 3 | 3 | 159 |
GO:0000785 | chromatin | 6.51e-02 | 1.00e+00 | 2.265 | 2 | 2 | 73 |
GO:0007051 | spindle organization | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0043968 | histone H2A acetylation | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0097372 | NAD-dependent histone deacetylase activity (H3-K18 specific) | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0055003 | cardiac myofibril assembly | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0061136 | regulation of proteasomal protein catabolic process | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0032041 | NAD-dependent histone deacetylase activity (H3-K14 specific) | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific) | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0048255 | mRNA stabilization | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0030140 | trans-Golgi network transport vesicle | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0072583 | clathrin-mediated endocytosis | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0047496 | vesicle transport along microtubule | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:1901214 | regulation of neuron death | 6.63e-02 | 1.00e+00 | 3.870 | 1 | 1 | 12 |
GO:0060070 | canonical Wnt signaling pathway | 6.82e-02 | 1.00e+00 | 2.226 | 2 | 2 | 75 |
GO:0031175 | neuron projection development | 6.82e-02 | 1.00e+00 | 2.226 | 2 | 2 | 75 |
GO:0044325 | ion channel binding | 7.14e-02 | 1.00e+00 | 2.188 | 2 | 3 | 77 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0001671 | ATPase activator activity | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0033290 | eukaryotic 48S preinitiation complex | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0031929 | TOR signaling | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0007080 | mitotic metaphase plate congression | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0004708 | MAP kinase kinase activity | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0005662 | DNA replication factor A complex | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0007062 | sister chromatid cohesion | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 2 | 13 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0035855 | megakaryocyte development | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0043488 | regulation of mRNA stability | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0046969 | NAD-dependent histone deacetylase activity (H3-K9 specific) | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0001833 | inner cell mass cell proliferation | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0042273 | ribosomal large subunit biogenesis | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0061647 | histone H3-K9 modification | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 1 | 13 |
GO:0007229 | integrin-mediated signaling pathway | 7.30e-02 | 1.00e+00 | 2.170 | 2 | 2 | 78 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 7.42e-02 | 1.00e+00 | 1.622 | 3 | 3 | 171 |
GO:0001822 | kidney development | 7.46e-02 | 1.00e+00 | 2.152 | 2 | 2 | 79 |
GO:0010629 | negative regulation of gene expression | 7.63e-02 | 1.00e+00 | 2.133 | 2 | 2 | 80 |
GO:0031333 | negative regulation of protein complex assembly | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0016282 | eukaryotic 43S preinitiation complex | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0050662 | coenzyme binding | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0015671 | oxygen transport | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0060292 | long term synaptic depression | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0032465 | regulation of cytokinesis | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0043539 | protein serine/threonine kinase activator activity | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0035371 | microtubule plus-end | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0070848 | response to growth factor | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0006595 | polyamine metabolic process | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0051298 | centrosome duplication | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0048488 | synaptic vesicle endocytosis | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0071480 | cellular response to gamma radiation | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0034185 | apolipoprotein binding | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0006165 | nucleoside diphosphate phosphorylation | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0005095 | GTPase inhibitor activity | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 14 |
GO:0007049 | cell cycle | 8.03e-02 | 1.00e+00 | 1.573 | 3 | 4 | 177 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.03e-02 | 1.00e+00 | 1.573 | 3 | 5 | 177 |
GO:0030336 | negative regulation of cell migration | 8.13e-02 | 1.00e+00 | 2.080 | 2 | 2 | 83 |
GO:0043197 | dendritic spine | 8.13e-02 | 1.00e+00 | 2.080 | 2 | 2 | 83 |
GO:0002042 | cell migration involved in sprouting angiogenesis | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0016514 | SWI/SNF complex | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0004550 | nucleoside diphosphate kinase activity | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:2000114 | regulation of establishment of cell polarity | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0042809 | vitamin D receptor binding | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0048477 | oogenesis | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0030131 | clathrin adaptor complex | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0016829 | lyase activity | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0045987 | positive regulation of smooth muscle contraction | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0045445 | myoblast differentiation | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0016010 | dystrophin-associated glycoprotein complex | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0008585 | female gonad development | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0051233 | spindle midzone | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 2 | 15 |
GO:0048854 | brain morphogenesis | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0060347 | heart trabecula formation | 8.22e-02 | 1.00e+00 | 3.548 | 1 | 1 | 15 |
GO:0031625 | ubiquitin protein ligase binding | 8.35e-02 | 1.00e+00 | 1.548 | 3 | 4 | 180 |
GO:0000139 | Golgi membrane | 8.36e-02 | 1.00e+00 | 1.105 | 5 | 7 | 408 |
GO:0007264 | small GTPase mediated signal transduction | 8.39e-02 | 1.00e+00 | 1.275 | 4 | 7 | 290 |
GO:0015629 | actin cytoskeleton | 8.68e-02 | 1.00e+00 | 1.525 | 3 | 3 | 183 |
GO:0032839 | dendrite cytoplasm | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0032012 | regulation of ARF protein signal transduction | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0048037 | cofactor binding | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0019226 | transmission of nerve impulse | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:2000811 | negative regulation of anoikis | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0043623 | cellular protein complex assembly | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0050775 | positive regulation of dendrite morphogenesis | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0007405 | neuroblast proliferation | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0014911 | positive regulation of smooth muscle cell migration | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0004407 | histone deacetylase activity | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0005099 | Ras GTPase activator activity | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0030220 | platelet formation | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 8.74e-02 | 1.00e+00 | 3.455 | 1 | 1 | 16 |
GO:0050852 | T cell receptor signaling pathway | 8.98e-02 | 1.00e+00 | 1.996 | 2 | 2 | 88 |
GO:0016601 | Rac protein signal transduction | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0035255 | ionotropic glutamate receptor binding | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0002548 | monocyte chemotaxis | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0070933 | histone H4 deacetylation | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0033365 | protein localization to organelle | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0043274 | phospholipase binding | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0008306 | associative learning | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0001829 | trophectodermal cell differentiation | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0009966 | regulation of signal transduction | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0001731 | formation of translation preinitiation complex | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0001556 | oocyte maturation | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0031527 | filopodium membrane | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0045070 | positive regulation of viral genome replication | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 2 | 17 |
GO:0007141 | male meiosis I | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0030742 | GTP-dependent protein binding | 9.26e-02 | 1.00e+00 | 3.368 | 1 | 1 | 17 |
GO:0042470 | melanosome | 9.68e-02 | 1.00e+00 | 1.932 | 2 | 2 | 92 |
GO:0016337 | single organismal cell-cell adhesion | 9.68e-02 | 1.00e+00 | 1.932 | 2 | 2 | 92 |
GO:0016363 | nuclear matrix | 9.68e-02 | 1.00e+00 | 1.932 | 2 | 4 | 92 |
GO:0006355 | regulation of transcription, DNA-templated | 9.73e-02 | 1.00e+00 | 0.669 | 10 | 10 | 1104 |
GO:0071889 | 14-3-3 protein binding | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0006612 | protein targeting to membrane | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 2 | 18 |
GO:0010507 | negative regulation of autophagy | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0090316 | positive regulation of intracellular protein transport | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0070064 | proline-rich region binding | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0045773 | positive regulation of axon extension | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0031954 | positive regulation of protein autophosphorylation | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0005086 | ARF guanyl-nucleotide exchange factor activity | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0015949 | nucleobase-containing small molecule interconversion | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0030100 | regulation of endocytosis | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0030532 | small nuclear ribonucleoprotein complex | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 1 | 18 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 1.00e-01 | 1.00e+00 | 1.901 | 2 | 2 | 94 |
GO:0001649 | osteoblast differentiation | 1.02e-01 | 1.00e+00 | 1.885 | 2 | 3 | 95 |
GO:0007088 | regulation of mitosis | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 19 |
GO:0010165 | response to X-ray | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 19 |
GO:0045453 | bone resorption | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 19 |
GO:0004674 | protein serine/threonine kinase activity | 1.03e-01 | 1.00e+00 | 1.170 | 4 | 6 | 312 |
GO:0006259 | DNA metabolic process | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 19 |
GO:0031667 | response to nutrient levels | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 19 |
GO:0035145 | exon-exon junction complex | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 19 |
GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 19 |
GO:0001764 | neuron migration | 1.04e-01 | 1.00e+00 | 1.870 | 2 | 2 | 96 |
GO:0035556 | intracellular signal transduction | 1.07e-01 | 1.00e+00 | 1.147 | 4 | 5 | 317 |
GO:0006915 | apoptotic process | 1.07e-01 | 1.00e+00 | 0.883 | 6 | 9 | 571 |
GO:0032148 | activation of protein kinase B activity | 1.08e-01 | 1.00e+00 | 3.133 | 1 | 1 | 20 |
GO:0090398 | cellular senescence | 1.08e-01 | 1.00e+00 | 3.133 | 1 | 1 | 20 |
GO:0001502 | cartilage condensation | 1.08e-01 | 1.00e+00 | 3.133 | 1 | 1 | 20 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 1.08e-01 | 1.00e+00 | 3.133 | 1 | 1 | 20 |
GO:0043393 | regulation of protein binding | 1.08e-01 | 1.00e+00 | 3.133 | 1 | 2 | 20 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.08e-01 | 1.00e+00 | 3.133 | 1 | 1 | 20 |
GO:0030544 | Hsp70 protein binding | 1.08e-01 | 1.00e+00 | 3.133 | 1 | 1 | 20 |
GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 1.08e-01 | 1.00e+00 | 3.133 | 1 | 1 | 20 |
GO:0016568 | chromatin modification | 1.09e-01 | 1.00e+00 | 1.826 | 2 | 2 | 99 |
GO:0006112 | energy reserve metabolic process | 1.09e-01 | 1.00e+00 | 1.826 | 2 | 2 | 99 |
GO:0003924 | GTPase activity | 1.10e-01 | 1.00e+00 | 1.375 | 3 | 6 | 203 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0042474 | middle ear morphogenesis | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0000245 | spliceosomal complex assembly | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0051881 | regulation of mitochondrial membrane potential | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0043021 | ribonucleoprotein complex binding | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0045648 | positive regulation of erythrocyte differentiation | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0007369 | gastrulation | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0015035 | protein disulfide oxidoreductase activity | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0000793 | condensed chromosome | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 2 | 21 |
GO:0043034 | costamere | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0070932 | histone H3 deacetylation | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0046847 | filopodium assembly | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 1 | 21 |
GO:0030316 | osteoclast differentiation | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0046686 | response to cadmium ion | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 2 | 22 |
GO:0030863 | cortical cytoskeleton | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0007052 | mitotic spindle organization | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0033574 | response to testosterone | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0031016 | pancreas development | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0005790 | smooth endoplasmic reticulum | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0001106 | RNA polymerase II transcription corepressor activity | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 1 | 22 |
GO:0006270 | DNA replication initiation | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 2 | 22 |
GO:0051491 | positive regulation of filopodium assembly | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 2 | 23 |
GO:0071944 | cell periphery | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 1 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 1 | 23 |
GO:0001892 | embryonic placenta development | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 1 | 23 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 1 | 23 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 1 | 23 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 1 | 23 |
GO:0002040 | sprouting angiogenesis | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 1 | 23 |
GO:0008060 | ARF GTPase activator activity | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 1 | 23 |
GO:0051297 | centrosome organization | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 2 | 23 |
GO:0003682 | chromatin binding | 1.23e-01 | 1.00e+00 | 1.072 | 4 | 4 | 334 |
GO:0007596 | blood coagulation | 1.25e-01 | 1.00e+00 | 0.919 | 5 | 5 | 464 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.28e-01 | 1.00e+00 | 2.870 | 1 | 1 | 24 |
GO:0046329 | negative regulation of JNK cascade | 1.28e-01 | 1.00e+00 | 2.870 | 1 | 1 | 24 |
GO:0048147 | negative regulation of fibroblast proliferation | 1.28e-01 | 1.00e+00 | 2.870 | 1 | 1 | 24 |
GO:0051602 | response to electrical stimulus | 1.28e-01 | 1.00e+00 | 2.870 | 1 | 1 | 24 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.28e-01 | 1.00e+00 | 2.870 | 1 | 1 | 24 |
GO:0005761 | mitochondrial ribosome | 1.28e-01 | 1.00e+00 | 2.870 | 1 | 1 | 24 |
GO:0005815 | microtubule organizing center | 1.30e-01 | 1.00e+00 | 1.674 | 2 | 4 | 110 |
GO:0006184 | GTP catabolic process | 1.31e-01 | 1.00e+00 | 1.259 | 3 | 6 | 220 |
GO:0032781 | positive regulation of ATPase activity | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0045296 | cadherin binding | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0048705 | skeletal system morphogenesis | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0006611 | protein export from nucleus | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0071479 | cellular response to ionizing radiation | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 2 | 25 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0050715 | positive regulation of cytokine secretion | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0007569 | cell aging | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 1 | 25 |
GO:0015630 | microtubule cytoskeleton | 1.34e-01 | 1.00e+00 | 1.648 | 2 | 4 | 112 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 1 | 26 |
GO:0045859 | regulation of protein kinase activity | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 1 | 26 |
GO:0048589 | developmental growth | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 1 | 26 |
GO:0000722 | telomere maintenance via recombination | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 2 | 26 |
GO:0046966 | thyroid hormone receptor binding | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 1 | 26 |
GO:0045214 | sarcomere organization | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 1 | 26 |
GO:0005819 | spindle | 1.38e-01 | 1.00e+00 | 1.622 | 2 | 4 | 114 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 1 | 26 |
GO:0001707 | mesoderm formation | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 1 | 26 |
GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 1 | 26 |
GO:0005635 | nuclear envelope | 1.42e-01 | 1.00e+00 | 1.597 | 2 | 2 | 116 |
GO:0031424 | keratinization | 1.43e-01 | 1.00e+00 | 2.700 | 1 | 1 | 27 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 1.43e-01 | 1.00e+00 | 2.700 | 1 | 1 | 27 |
GO:0030331 | estrogen receptor binding | 1.43e-01 | 1.00e+00 | 2.700 | 1 | 1 | 27 |
GO:0048565 | digestive tract development | 1.43e-01 | 1.00e+00 | 2.700 | 1 | 1 | 27 |
GO:0032720 | negative regulation of tumor necrosis factor production | 1.43e-01 | 1.00e+00 | 2.700 | 1 | 1 | 27 |
GO:0007616 | long-term memory | 1.43e-01 | 1.00e+00 | 2.700 | 1 | 1 | 27 |
GO:0005083 | small GTPase regulator activity | 1.43e-01 | 1.00e+00 | 2.700 | 1 | 1 | 27 |
GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 1.43e-01 | 1.00e+00 | 2.700 | 1 | 1 | 27 |
GO:0031069 | hair follicle morphogenesis | 1.43e-01 | 1.00e+00 | 2.700 | 1 | 1 | 27 |
GO:0003677 | DNA binding | 1.45e-01 | 1.00e+00 | 0.515 | 11 | 14 | 1351 |
GO:0005524 | ATP binding | 1.47e-01 | 1.00e+00 | 0.512 | 11 | 19 | 1354 |
GO:0032467 | positive regulation of cytokinesis | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 1 | 28 |
GO:0019894 | kinesin binding | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 1 | 28 |
GO:0005875 | microtubule associated complex | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 1 | 28 |
GO:0000118 | histone deacetylase complex | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 1 | 28 |
GO:0000077 | DNA damage checkpoint | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 1 | 28 |
GO:0031492 | nucleosomal DNA binding | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 1 | 28 |
GO:0045597 | positive regulation of cell differentiation | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 1 | 28 |
GO:0007017 | microtubule-based process | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 2 | 28 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 1 | 29 |
GO:0003730 | mRNA 3'-UTR binding | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 1 | 29 |
GO:0048365 | Rac GTPase binding | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 1 | 29 |
GO:0034605 | cellular response to heat | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 1 | 29 |
GO:0072686 | mitotic spindle | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 1 | 29 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 1 | 29 |
GO:0006325 | chromatin organization | 1.55e-01 | 1.00e+00 | 1.513 | 2 | 2 | 123 |
GO:0030425 | dendrite | 1.57e-01 | 1.00e+00 | 1.133 | 3 | 3 | 240 |
GO:0010977 | negative regulation of neuron projection development | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 2 | 30 |
GO:0007346 | regulation of mitotic cell cycle | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 3 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 1 | 30 |
GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 1 | 30 |
GO:0002027 | regulation of heart rate | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 2 | 30 |
GO:0040018 | positive regulation of multicellular organism growth | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 1 | 30 |
GO:0001618 | virus receptor activity | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 1 | 30 |
GO:0051262 | protein tetramerization | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 1 | 30 |
GO:0070491 | repressing transcription factor binding | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 1 | 30 |
GO:0042169 | SH2 domain binding | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 1 | 30 |
GO:0031647 | regulation of protein stability | 1.58e-01 | 1.00e+00 | 2.548 | 1 | 1 | 30 |
GO:0007050 | cell cycle arrest | 1.61e-01 | 1.00e+00 | 1.478 | 2 | 2 | 126 |
GO:0045171 | intercellular bridge | 1.62e-01 | 1.00e+00 | 2.501 | 1 | 2 | 31 |
GO:0070555 | response to interleukin-1 | 1.62e-01 | 1.00e+00 | 2.501 | 1 | 1 | 31 |
GO:0006271 | DNA strand elongation involved in DNA replication | 1.62e-01 | 1.00e+00 | 2.501 | 1 | 2 | 31 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 1.62e-01 | 1.00e+00 | 2.501 | 1 | 1 | 31 |
GO:0061077 | chaperone-mediated protein folding | 1.62e-01 | 1.00e+00 | 2.501 | 1 | 1 | 31 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.63e-01 | 1.00e+00 | 1.467 | 2 | 3 | 127 |
GO:0005794 | Golgi apparatus | 1.66e-01 | 1.00e+00 | 0.696 | 6 | 8 | 650 |
GO:0034644 | cellular response to UV | 1.67e-01 | 1.00e+00 | 2.455 | 1 | 1 | 32 |
GO:0030036 | actin cytoskeleton organization | 1.67e-01 | 1.00e+00 | 1.444 | 2 | 3 | 129 |
GO:0002062 | chondrocyte differentiation | 1.67e-01 | 1.00e+00 | 2.455 | 1 | 1 | 32 |
GO:0070888 | E-box binding | 1.67e-01 | 1.00e+00 | 2.455 | 1 | 1 | 32 |
GO:0032320 | positive regulation of Ras GTPase activity | 1.67e-01 | 1.00e+00 | 2.455 | 1 | 1 | 32 |
GO:0030027 | lamellipodium | 1.69e-01 | 1.00e+00 | 1.433 | 2 | 3 | 130 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 1.72e-01 | 1.00e+00 | 2.411 | 1 | 1 | 33 |
GO:0070830 | tight junction assembly | 1.72e-01 | 1.00e+00 | 2.411 | 1 | 1 | 33 |
GO:0030971 | receptor tyrosine kinase binding | 1.72e-01 | 1.00e+00 | 2.411 | 1 | 1 | 33 |
GO:0048812 | neuron projection morphogenesis | 1.72e-01 | 1.00e+00 | 2.411 | 1 | 1 | 33 |
GO:0032091 | negative regulation of protein binding | 1.72e-01 | 1.00e+00 | 2.411 | 1 | 1 | 33 |
GO:0033077 | T cell differentiation in thymus | 1.72e-01 | 1.00e+00 | 2.411 | 1 | 1 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 1.72e-01 | 1.00e+00 | 2.411 | 1 | 2 | 33 |
GO:0000790 | nuclear chromatin | 1.76e-01 | 1.00e+00 | 1.400 | 2 | 2 | 133 |
GO:0001890 | placenta development | 1.77e-01 | 1.00e+00 | 2.368 | 1 | 1 | 34 |
GO:0045071 | negative regulation of viral genome replication | 1.77e-01 | 1.00e+00 | 2.368 | 1 | 2 | 34 |
GO:0001569 | patterning of blood vessels | 1.77e-01 | 1.00e+00 | 2.368 | 1 | 1 | 34 |
GO:0007611 | learning or memory | 1.77e-01 | 1.00e+00 | 2.368 | 1 | 2 | 34 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 1.81e-01 | 1.00e+00 | 2.326 | 1 | 1 | 35 |
GO:0009725 | response to hormone | 1.81e-01 | 1.00e+00 | 2.326 | 1 | 1 | 35 |
GO:0048666 | neuron development | 1.81e-01 | 1.00e+00 | 2.326 | 1 | 1 | 35 |
GO:0016592 | mediator complex | 1.81e-01 | 1.00e+00 | 2.326 | 1 | 2 | 35 |
GO:0051402 | neuron apoptotic process | 1.86e-01 | 1.00e+00 | 2.285 | 1 | 1 | 36 |
GO:0000228 | nuclear chromosome | 1.86e-01 | 1.00e+00 | 2.285 | 1 | 2 | 36 |
GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process | 1.86e-01 | 1.00e+00 | 2.285 | 1 | 1 | 36 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 1.86e-01 | 1.00e+00 | 2.285 | 1 | 1 | 36 |
GO:0007257 | activation of JUN kinase activity | 1.86e-01 | 1.00e+00 | 2.285 | 1 | 1 | 36 |
GO:0030178 | negative regulation of Wnt signaling pathway | 1.86e-01 | 1.00e+00 | 2.285 | 1 | 1 | 36 |
GO:0001895 | retina homeostasis | 1.86e-01 | 1.00e+00 | 2.285 | 1 | 1 | 36 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 1 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 2 | 37 |
GO:0005791 | rough endoplasmic reticulum | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 1 | 37 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 1 | 37 |
GO:0032880 | regulation of protein localization | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 1 | 37 |
GO:0016301 | kinase activity | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 2 | 37 |
GO:0006633 | fatty acid biosynthetic process | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 1 | 37 |
GO:0006281 | DNA repair | 1.91e-01 | 1.00e+00 | 0.996 | 3 | 5 | 264 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 1 | 37 |
GO:0071277 | cellular response to calcium ion | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 1 | 37 |
GO:0005911 | cell-cell junction | 1.94e-01 | 1.00e+00 | 1.306 | 2 | 2 | 142 |
GO:0001568 | blood vessel development | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 2 | 38 |
GO:0070527 | platelet aggregation | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 1 | 38 |
GO:0030049 | muscle filament sliding | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 2 | 38 |
GO:0045740 | positive regulation of DNA replication | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 1 | 38 |
GO:0008286 | insulin receptor signaling pathway | 1.98e-01 | 1.00e+00 | 1.285 | 2 | 4 | 144 |
GO:0032092 | positive regulation of protein binding | 2.00e-01 | 1.00e+00 | 2.170 | 1 | 1 | 39 |
GO:0031490 | chromatin DNA binding | 2.00e-01 | 1.00e+00 | 2.170 | 1 | 1 | 39 |
GO:0051781 | positive regulation of cell division | 2.00e-01 | 1.00e+00 | 2.170 | 1 | 1 | 39 |
GO:0060048 | cardiac muscle contraction | 2.00e-01 | 1.00e+00 | 2.170 | 1 | 1 | 39 |
GO:0001933 | negative regulation of protein phosphorylation | 2.00e-01 | 1.00e+00 | 2.170 | 1 | 1 | 39 |
GO:0042542 | response to hydrogen peroxide | 2.05e-01 | 1.00e+00 | 2.133 | 1 | 1 | 40 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.05e-01 | 1.00e+00 | 2.133 | 1 | 1 | 40 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 2.06e-01 | 1.00e+00 | 1.246 | 2 | 3 | 148 |
GO:0051117 | ATPase binding | 2.09e-01 | 1.00e+00 | 2.098 | 1 | 2 | 41 |
GO:0008307 | structural constituent of muscle | 2.09e-01 | 1.00e+00 | 2.098 | 1 | 1 | 41 |
GO:0017148 | negative regulation of translation | 2.09e-01 | 1.00e+00 | 2.098 | 1 | 1 | 41 |
GO:0050885 | neuromuscular process controlling balance | 2.09e-01 | 1.00e+00 | 2.098 | 1 | 1 | 41 |
GO:0007519 | skeletal muscle tissue development | 2.09e-01 | 1.00e+00 | 2.098 | 1 | 1 | 41 |
GO:0070301 | cellular response to hydrogen peroxide | 2.09e-01 | 1.00e+00 | 2.098 | 1 | 1 | 41 |
GO:0006457 | protein folding | 2.09e-01 | 1.00e+00 | 1.236 | 2 | 3 | 149 |
GO:0045785 | positive regulation of cell adhesion | 2.09e-01 | 1.00e+00 | 2.098 | 1 | 1 | 41 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.13e-01 | 1.00e+00 | 1.217 | 2 | 2 | 151 |
GO:0031532 | actin cytoskeleton reorganization | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 2 | 42 |
GO:0021987 | cerebral cortex development | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 1 | 42 |
GO:0030155 | regulation of cell adhesion | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 1 | 42 |
GO:0009898 | cytoplasmic side of plasma membrane | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 1 | 42 |
GO:0005902 | microvillus | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 1 | 42 |
GO:0035914 | skeletal muscle cell differentiation | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 1 | 42 |
GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 1 | 42 |
GO:0004984 | olfactory receptor activity | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 1 | 42 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 1 | 42 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 2.18e-01 | 1.00e+00 | 2.029 | 1 | 1 | 43 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 2.18e-01 | 1.00e+00 | 2.029 | 1 | 1 | 43 |
GO:0004402 | histone acetyltransferase activity | 2.18e-01 | 1.00e+00 | 2.029 | 1 | 1 | 43 |
GO:0007286 | spermatid development | 2.23e-01 | 1.00e+00 | 1.996 | 1 | 1 | 44 |
GO:0003712 | transcription cofactor activity | 2.23e-01 | 1.00e+00 | 1.996 | 1 | 1 | 44 |
GO:0005871 | kinesin complex | 2.23e-01 | 1.00e+00 | 1.996 | 1 | 1 | 44 |
GO:0005080 | protein kinase C binding | 2.23e-01 | 1.00e+00 | 1.996 | 1 | 1 | 44 |
GO:0050896 | response to stimulus | 2.23e-01 | 1.00e+00 | 1.996 | 1 | 1 | 44 |
GO:0048146 | positive regulation of fibroblast proliferation | 2.23e-01 | 1.00e+00 | 1.996 | 1 | 1 | 44 |
GO:0010008 | endosome membrane | 2.25e-01 | 1.00e+00 | 1.161 | 2 | 2 | 157 |
GO:0005788 | endoplasmic reticulum lumen | 2.25e-01 | 1.00e+00 | 1.161 | 2 | 2 | 157 |
GO:0006974 | cellular response to DNA damage stimulus | 2.27e-01 | 1.00e+00 | 1.152 | 2 | 3 | 158 |
GO:0043966 | histone H3 acetylation | 2.27e-01 | 1.00e+00 | 1.963 | 1 | 1 | 45 |
GO:0045860 | positive regulation of protein kinase activity | 2.27e-01 | 1.00e+00 | 1.963 | 1 | 1 | 45 |
GO:0051591 | response to cAMP | 2.27e-01 | 1.00e+00 | 1.963 | 1 | 1 | 45 |
GO:0001047 | core promoter binding | 2.31e-01 | 1.00e+00 | 1.932 | 1 | 1 | 46 |
GO:0044297 | cell body | 2.31e-01 | 1.00e+00 | 1.932 | 1 | 1 | 46 |
GO:0045727 | positive regulation of translation | 2.31e-01 | 1.00e+00 | 1.932 | 1 | 1 | 46 |
GO:0005884 | actin filament | 2.31e-01 | 1.00e+00 | 1.932 | 1 | 2 | 46 |
GO:0008022 | protein C-terminus binding | 2.34e-01 | 1.00e+00 | 1.124 | 2 | 4 | 161 |
GO:0005516 | calmodulin binding | 2.36e-01 | 1.00e+00 | 1.115 | 2 | 3 | 162 |
GO:0043406 | positive regulation of MAP kinase activity | 2.36e-01 | 1.00e+00 | 1.901 | 1 | 1 | 47 |
GO:0006950 | response to stress | 2.40e-01 | 1.00e+00 | 1.870 | 1 | 1 | 48 |
GO:0019003 | GDP binding | 2.40e-01 | 1.00e+00 | 1.870 | 1 | 1 | 48 |
GO:0007266 | Rho protein signal transduction | 2.40e-01 | 1.00e+00 | 1.870 | 1 | 1 | 48 |
GO:0000398 | mRNA splicing, via spliceosome | 2.42e-01 | 1.00e+00 | 1.089 | 2 | 2 | 165 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 2.45e-01 | 1.00e+00 | 1.841 | 1 | 2 | 49 |
GO:0005070 | SH3/SH2 adaptor activity | 2.45e-01 | 1.00e+00 | 1.841 | 1 | 1 | 49 |
GO:0001947 | heart looping | 2.45e-01 | 1.00e+00 | 1.841 | 1 | 1 | 49 |
GO:0022625 | cytosolic large ribosomal subunit | 2.45e-01 | 1.00e+00 | 1.841 | 1 | 1 | 49 |
GO:0005739 | mitochondrion | 2.45e-01 | 1.00e+00 | 0.425 | 8 | 10 | 1046 |
GO:0034220 | ion transmembrane transport | 2.46e-01 | 1.00e+00 | 1.072 | 2 | 2 | 167 |
GO:0034097 | response to cytokine | 2.49e-01 | 1.00e+00 | 1.811 | 1 | 1 | 50 |
GO:0001948 | glycoprotein binding | 2.49e-01 | 1.00e+00 | 1.811 | 1 | 2 | 50 |
GO:0006397 | mRNA processing | 2.51e-01 | 1.00e+00 | 1.054 | 2 | 3 | 169 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 2.53e-01 | 1.00e+00 | 1.783 | 1 | 1 | 51 |
GO:0000902 | cell morphogenesis | 2.53e-01 | 1.00e+00 | 1.783 | 1 | 1 | 51 |
GO:0030900 | forebrain development | 2.53e-01 | 1.00e+00 | 1.783 | 1 | 1 | 51 |
GO:0040008 | regulation of growth | 2.53e-01 | 1.00e+00 | 1.783 | 1 | 1 | 51 |
GO:0000910 | cytokinesis | 2.53e-01 | 1.00e+00 | 1.783 | 1 | 2 | 51 |
GO:0003684 | damaged DNA binding | 2.53e-01 | 1.00e+00 | 1.783 | 1 | 2 | 51 |
GO:0045732 | positive regulation of protein catabolic process | 2.53e-01 | 1.00e+00 | 1.783 | 1 | 1 | 51 |
GO:0008202 | steroid metabolic process | 2.57e-01 | 1.00e+00 | 1.755 | 1 | 1 | 52 |
GO:0004197 | cysteine-type endopeptidase activity | 2.57e-01 | 1.00e+00 | 1.755 | 1 | 2 | 52 |
GO:0045454 | cell redox homeostasis | 2.57e-01 | 1.00e+00 | 1.755 | 1 | 1 | 52 |
GO:0007420 | brain development | 2.57e-01 | 1.00e+00 | 1.029 | 2 | 3 | 172 |
GO:0034976 | response to endoplasmic reticulum stress | 2.57e-01 | 1.00e+00 | 1.755 | 1 | 1 | 52 |
GO:0016042 | lipid catabolic process | 2.57e-01 | 1.00e+00 | 1.755 | 1 | 2 | 52 |
GO:0005856 | cytoskeleton | 2.61e-01 | 1.00e+00 | 0.759 | 3 | 6 | 311 |
GO:0006952 | defense response | 2.62e-01 | 1.00e+00 | 1.727 | 1 | 1 | 53 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.62e-01 | 1.00e+00 | 1.727 | 1 | 1 | 53 |
GO:0031965 | nuclear membrane | 2.65e-01 | 1.00e+00 | 0.996 | 2 | 2 | 176 |
GO:0003725 | double-stranded RNA binding | 2.66e-01 | 1.00e+00 | 1.700 | 1 | 2 | 54 |
GO:0009612 | response to mechanical stimulus | 2.66e-01 | 1.00e+00 | 1.700 | 1 | 1 | 54 |
GO:0019900 | kinase binding | 2.66e-01 | 1.00e+00 | 1.700 | 1 | 3 | 54 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.66e-01 | 1.00e+00 | 1.700 | 1 | 1 | 54 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.66e-01 | 1.00e+00 | 1.700 | 1 | 1 | 54 |
GO:0050680 | negative regulation of epithelial cell proliferation | 2.66e-01 | 1.00e+00 | 1.700 | 1 | 1 | 54 |
GO:0045211 | postsynaptic membrane | 2.67e-01 | 1.00e+00 | 0.988 | 2 | 3 | 177 |
GO:0002039 | p53 binding | 2.70e-01 | 1.00e+00 | 1.674 | 1 | 1 | 55 |
GO:0000226 | microtubule cytoskeleton organization | 2.70e-01 | 1.00e+00 | 1.674 | 1 | 1 | 55 |
GO:0046330 | positive regulation of JNK cascade | 2.70e-01 | 1.00e+00 | 1.674 | 1 | 1 | 55 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 2.70e-01 | 1.00e+00 | 1.674 | 1 | 1 | 55 |
GO:0000932 | cytoplasmic mRNA processing body | 2.74e-01 | 1.00e+00 | 1.648 | 1 | 1 | 56 |
GO:0004386 | helicase activity | 2.74e-01 | 1.00e+00 | 1.648 | 1 | 1 | 56 |
GO:0006879 | cellular iron ion homeostasis | 2.78e-01 | 1.00e+00 | 1.622 | 1 | 2 | 57 |
GO:0000724 | double-strand break repair via homologous recombination | 2.78e-01 | 1.00e+00 | 1.622 | 1 | 2 | 57 |
GO:0005764 | lysosome | 2.78e-01 | 1.00e+00 | 0.947 | 2 | 2 | 182 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 2.78e-01 | 1.00e+00 | 1.622 | 1 | 1 | 57 |
GO:0030097 | hemopoiesis | 2.83e-01 | 1.00e+00 | 1.597 | 1 | 1 | 58 |
GO:0032403 | protein complex binding | 2.84e-01 | 1.00e+00 | 0.924 | 2 | 2 | 185 |
GO:0007411 | axon guidance | 2.86e-01 | 1.00e+00 | 0.687 | 3 | 3 | 327 |
GO:0005643 | nuclear pore | 2.87e-01 | 1.00e+00 | 1.573 | 1 | 1 | 59 |
GO:0005525 | GTP binding | 2.87e-01 | 1.00e+00 | 0.683 | 3 | 6 | 328 |
GO:0051087 | chaperone binding | 2.87e-01 | 1.00e+00 | 1.573 | 1 | 1 | 59 |
GO:0000723 | telomere maintenance | 2.87e-01 | 1.00e+00 | 1.573 | 1 | 2 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 2.87e-01 | 1.00e+00 | 1.573 | 1 | 1 | 59 |
GO:0050728 | negative regulation of inflammatory response | 2.91e-01 | 1.00e+00 | 1.548 | 1 | 2 | 60 |
GO:0043231 | intracellular membrane-bounded organelle | 2.94e-01 | 1.00e+00 | 0.665 | 3 | 3 | 332 |
GO:0003705 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity | 2.95e-01 | 1.00e+00 | 1.525 | 1 | 1 | 61 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 2.95e-01 | 1.00e+00 | 1.525 | 1 | 1 | 61 |
GO:0006302 | double-strand break repair | 2.99e-01 | 1.00e+00 | 1.501 | 1 | 2 | 62 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 2.99e-01 | 1.00e+00 | 1.501 | 1 | 1 | 62 |
GO:0000151 | ubiquitin ligase complex | 3.03e-01 | 1.00e+00 | 1.478 | 1 | 1 | 63 |
GO:0005901 | caveola | 3.03e-01 | 1.00e+00 | 1.478 | 1 | 1 | 63 |
GO:0060337 | type I interferon signaling pathway | 3.03e-01 | 1.00e+00 | 1.478 | 1 | 1 | 63 |
GO:0000776 | kinetochore | 3.03e-01 | 1.00e+00 | 1.478 | 1 | 3 | 63 |
GO:0019903 | protein phosphatase binding | 3.03e-01 | 1.00e+00 | 1.478 | 1 | 1 | 63 |
GO:0042995 | cell projection | 3.03e-01 | 1.00e+00 | 1.478 | 1 | 1 | 63 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 3.03e-01 | 1.00e+00 | 1.478 | 1 | 2 | 63 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 3.07e-01 | 1.00e+00 | 1.455 | 1 | 1 | 64 |
GO:0032869 | cellular response to insulin stimulus | 3.07e-01 | 1.00e+00 | 1.455 | 1 | 2 | 64 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 3.07e-01 | 1.00e+00 | 1.455 | 1 | 1 | 64 |
GO:0007059 | chromosome segregation | 3.07e-01 | 1.00e+00 | 1.455 | 1 | 3 | 64 |
GO:0016491 | oxidoreductase activity | 3.11e-01 | 1.00e+00 | 1.433 | 1 | 1 | 65 |
GO:0006469 | negative regulation of protein kinase activity | 3.11e-01 | 1.00e+00 | 1.433 | 1 | 1 | 65 |
GO:0043202 | lysosomal lumen | 3.15e-01 | 1.00e+00 | 1.411 | 1 | 1 | 66 |
GO:0009636 | response to toxic substance | 3.15e-01 | 1.00e+00 | 1.411 | 1 | 1 | 66 |
GO:0001525 | angiogenesis | 3.16e-01 | 1.00e+00 | 0.811 | 2 | 3 | 200 |
GO:0045666 | positive regulation of neuron differentiation | 3.23e-01 | 1.00e+00 | 1.368 | 1 | 1 | 68 |
GO:0046872 | metal ion binding | 3.23e-01 | 1.00e+00 | 0.261 | 10 | 14 | 1465 |
GO:0006289 | nucleotide-excision repair | 3.26e-01 | 1.00e+00 | 1.347 | 1 | 1 | 69 |
GO:0050790 | regulation of catalytic activity | 3.26e-01 | 1.00e+00 | 1.347 | 1 | 1 | 69 |
GO:0006887 | exocytosis | 3.26e-01 | 1.00e+00 | 1.347 | 1 | 1 | 69 |
GO:0035264 | multicellular organism growth | 3.30e-01 | 1.00e+00 | 1.326 | 1 | 1 | 70 |
GO:0030054 | cell junction | 3.31e-01 | 1.00e+00 | 0.565 | 3 | 4 | 356 |
GO:0042393 | histone binding | 3.34e-01 | 1.00e+00 | 1.306 | 1 | 1 | 71 |
GO:0042383 | sarcolemma | 3.34e-01 | 1.00e+00 | 1.306 | 1 | 2 | 71 |
GO:0001701 | in utero embryonic development | 3.37e-01 | 1.00e+00 | 0.741 | 2 | 2 | 210 |
GO:0000165 | MAPK cascade | 3.38e-01 | 1.00e+00 | 1.285 | 1 | 2 | 72 |
GO:0010468 | regulation of gene expression | 3.38e-01 | 1.00e+00 | 1.285 | 1 | 1 | 72 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.42e-01 | 1.00e+00 | 1.265 | 1 | 2 | 73 |
GO:0042826 | histone deacetylase binding | 3.45e-01 | 1.00e+00 | 1.246 | 1 | 1 | 74 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 3.45e-01 | 1.00e+00 | 1.246 | 1 | 1 | 74 |
GO:0002020 | protease binding | 3.45e-01 | 1.00e+00 | 1.246 | 1 | 1 | 74 |
GO:0043086 | negative regulation of catalytic activity | 3.45e-01 | 1.00e+00 | 1.246 | 1 | 1 | 74 |
GO:0008285 | negative regulation of cell proliferation | 3.48e-01 | 1.00e+00 | 0.521 | 3 | 3 | 367 |
GO:0051897 | positive regulation of protein kinase B signaling | 3.49e-01 | 1.00e+00 | 1.226 | 1 | 1 | 75 |
GO:0009791 | post-embryonic development | 3.49e-01 | 1.00e+00 | 1.226 | 1 | 1 | 75 |
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 3.49e-01 | 1.00e+00 | 1.226 | 1 | 1 | 75 |
GO:0008584 | male gonad development | 3.57e-01 | 1.00e+00 | 1.188 | 1 | 1 | 77 |
GO:0017137 | Rab GTPase binding | 3.60e-01 | 1.00e+00 | 1.170 | 1 | 1 | 78 |
GO:0071013 | catalytic step 2 spliceosome | 3.64e-01 | 1.00e+00 | 1.152 | 1 | 1 | 79 |
GO:0016874 | ligase activity | 3.66e-01 | 1.00e+00 | 0.648 | 2 | 2 | 224 |
GO:0004725 | protein tyrosine phosphatase activity | 3.68e-01 | 1.00e+00 | 1.133 | 1 | 1 | 80 |
GO:0005814 | centriole | 3.68e-01 | 1.00e+00 | 1.133 | 1 | 1 | 80 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 3.71e-01 | 1.00e+00 | 1.115 | 1 | 1 | 81 |
GO:0050796 | regulation of insulin secretion | 3.75e-01 | 1.00e+00 | 1.098 | 1 | 1 | 82 |
GO:0045177 | apical part of cell | 3.75e-01 | 1.00e+00 | 1.098 | 1 | 1 | 82 |
GO:0001726 | ruffle | 3.75e-01 | 1.00e+00 | 1.098 | 1 | 1 | 82 |
GO:0004713 | protein tyrosine kinase activity | 3.75e-01 | 1.00e+00 | 1.098 | 1 | 1 | 82 |
GO:0007517 | muscle organ development | 3.78e-01 | 1.00e+00 | 1.080 | 1 | 1 | 83 |
GO:0005929 | cilium | 3.82e-01 | 1.00e+00 | 1.063 | 1 | 2 | 84 |
GO:0005179 | hormone activity | 3.82e-01 | 1.00e+00 | 1.063 | 1 | 1 | 84 |
GO:0047485 | protein N-terminus binding | 3.89e-01 | 1.00e+00 | 1.029 | 1 | 1 | 86 |
GO:0007160 | cell-matrix adhesion | 3.96e-01 | 1.00e+00 | 0.996 | 1 | 1 | 88 |
GO:0042593 | glucose homeostasis | 3.99e-01 | 1.00e+00 | 0.980 | 1 | 1 | 89 |
GO:0042384 | cilium assembly | 4.03e-01 | 1.00e+00 | 0.963 | 1 | 2 | 90 |
GO:0003690 | double-stranded DNA binding | 4.06e-01 | 1.00e+00 | 0.947 | 1 | 2 | 91 |
GO:0018279 | protein N-linked glycosylation via asparagine | 4.06e-01 | 1.00e+00 | 0.947 | 1 | 1 | 91 |
GO:0016605 | PML body | 4.10e-01 | 1.00e+00 | 0.932 | 1 | 2 | 92 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 4.13e-01 | 1.00e+00 | 0.916 | 1 | 1 | 93 |
GO:0005770 | late endosome | 4.16e-01 | 1.00e+00 | 0.901 | 1 | 1 | 94 |
GO:0051082 | unfolded protein binding | 4.20e-01 | 1.00e+00 | 0.885 | 1 | 1 | 95 |
GO:0051015 | actin filament binding | 4.26e-01 | 1.00e+00 | 0.855 | 1 | 1 | 97 |
GO:0005178 | integrin binding | 4.26e-01 | 1.00e+00 | 0.855 | 1 | 1 | 97 |
GO:0004842 | ubiquitin-protein transferase activity | 4.30e-01 | 1.00e+00 | 0.455 | 2 | 3 | 256 |
GO:0005874 | microtubule | 4.34e-01 | 1.00e+00 | 0.444 | 2 | 3 | 258 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.38e-01 | 1.00e+00 | 0.309 | 3 | 3 | 425 |
GO:0051726 | regulation of cell cycle | 4.43e-01 | 1.00e+00 | 0.783 | 1 | 2 | 102 |
GO:0004888 | transmembrane signaling receptor activity | 4.46e-01 | 1.00e+00 | 0.769 | 1 | 1 | 103 |
GO:0005102 | receptor binding | 4.53e-01 | 1.00e+00 | 0.389 | 2 | 2 | 268 |
GO:0007165 | signal transduction | 4.58e-01 | 1.00e+00 | 0.148 | 6 | 7 | 950 |
GO:0005783 | endoplasmic reticulum | 4.60e-01 | 1.00e+00 | 0.203 | 4 | 6 | 610 |
GO:0044281 | small molecule metabolic process | 4.60e-01 | 1.00e+00 | 0.117 | 8 | 16 | 1295 |
GO:0006935 | chemotaxis | 4.62e-01 | 1.00e+00 | 0.700 | 1 | 1 | 108 |
GO:0005975 | carbohydrate metabolic process | 4.65e-01 | 1.00e+00 | 0.357 | 2 | 3 | 274 |
GO:0005938 | cell cortex | 4.65e-01 | 1.00e+00 | 0.687 | 1 | 1 | 109 |
GO:0007283 | spermatogenesis | 4.68e-01 | 1.00e+00 | 0.347 | 2 | 2 | 276 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 4.68e-01 | 1.00e+00 | 0.674 | 1 | 1 | 110 |
GO:0031410 | cytoplasmic vesicle | 4.68e-01 | 1.00e+00 | 0.674 | 1 | 1 | 110 |
GO:0042803 | protein homodimerization activity | 4.69e-01 | 1.00e+00 | 0.186 | 4 | 4 | 617 |
GO:0050900 | leukocyte migration | 4.71e-01 | 1.00e+00 | 0.661 | 1 | 1 | 111 |
GO:0020037 | heme binding | 4.71e-01 | 1.00e+00 | 0.661 | 1 | 1 | 111 |
GO:0007605 | sensory perception of sound | 4.71e-01 | 1.00e+00 | 0.661 | 1 | 1 | 111 |
GO:0005802 | trans-Golgi network | 4.86e-01 | 1.00e+00 | 0.597 | 1 | 2 | 116 |
GO:0072562 | blood microparticle | 4.86e-01 | 1.00e+00 | 0.597 | 1 | 1 | 116 |
GO:0042493 | response to drug | 4.91e-01 | 1.00e+00 | 0.285 | 2 | 2 | 288 |
GO:0006468 | protein phosphorylation | 5.00e-01 | 1.00e+00 | 0.173 | 3 | 6 | 467 |
GO:0016192 | vesicle-mediated transport | 5.03e-01 | 1.00e+00 | 0.525 | 1 | 1 | 122 |
GO:0032496 | response to lipopolysaccharide | 5.03e-01 | 1.00e+00 | 0.525 | 1 | 1 | 122 |
GO:0007568 | aging | 5.06e-01 | 1.00e+00 | 0.513 | 1 | 2 | 123 |
GO:0001501 | skeletal system development | 5.06e-01 | 1.00e+00 | 0.513 | 1 | 1 | 123 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 5.06e-01 | 1.00e+00 | 0.513 | 1 | 3 | 123 |
GO:0008201 | heparin binding | 5.17e-01 | 1.00e+00 | 0.467 | 1 | 1 | 127 |
GO:0006200 | ATP catabolic process | 5.18e-01 | 1.00e+00 | 0.212 | 2 | 4 | 303 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 5.34e-01 | 1.00e+00 | 0.400 | 1 | 1 | 133 |
GO:0031982 | vesicle | 5.36e-01 | 1.00e+00 | 0.389 | 1 | 2 | 134 |
GO:0005575 | cellular_component | 5.51e-01 | 1.00e+00 | 0.124 | 2 | 2 | 322 |
GO:0045202 | synapse | 5.52e-01 | 1.00e+00 | 0.326 | 1 | 1 | 140 |
GO:0007507 | heart development | 5.55e-01 | 1.00e+00 | 0.316 | 1 | 1 | 141 |
GO:0030154 | cell differentiation | 5.56e-01 | 1.00e+00 | 0.111 | 2 | 3 | 325 |
GO:0005886 | plasma membrane | 5.59e-01 | 1.00e+00 | -0.013 | 16 | 24 | 2834 |
GO:0008283 | cell proliferation | 5.66e-01 | 1.00e+00 | 0.085 | 2 | 4 | 331 |
GO:0007166 | cell surface receptor signaling pathway | 5.75e-01 | 1.00e+00 | 0.236 | 1 | 1 | 149 |
GO:0008017 | microtubule binding | 5.77e-01 | 1.00e+00 | 0.226 | 1 | 2 | 150 |
GO:0001666 | response to hypoxia | 5.77e-01 | 1.00e+00 | 0.226 | 1 | 1 | 150 |
GO:0051260 | protein homooligomerization | 5.77e-01 | 1.00e+00 | 0.226 | 1 | 2 | 150 |
GO:0030246 | carbohydrate binding | 5.80e-01 | 1.00e+00 | 0.217 | 1 | 1 | 151 |
GO:0007275 | multicellular organismal development | 5.87e-01 | 1.00e+00 | 0.029 | 2 | 2 | 344 |
GO:0005769 | early endosome | 5.96e-01 | 1.00e+00 | 0.152 | 1 | 1 | 158 |
GO:0046777 | protein autophosphorylation | 5.96e-01 | 1.00e+00 | 0.152 | 1 | 1 | 158 |
GO:0045121 | membrane raft | 6.03e-01 | 1.00e+00 | 0.124 | 1 | 3 | 161 |
GO:0015031 | protein transport | 6.07e-01 | 1.00e+00 | -0.024 | 2 | 4 | 357 |
GO:0007601 | visual perception | 6.19e-01 | 1.00e+00 | 0.063 | 1 | 1 | 168 |
GO:0000287 | magnesium ion binding | 6.32e-01 | 1.00e+00 | 0.012 | 1 | 2 | 174 |
GO:0016607 | nuclear speck | 6.34e-01 | 1.00e+00 | 0.004 | 1 | 2 | 175 |
GO:0004672 | protein kinase activity | 6.40e-01 | 1.00e+00 | -0.020 | 1 | 4 | 178 |
GO:0019904 | protein domain specific binding | 6.47e-01 | 1.00e+00 | -0.045 | 1 | 3 | 181 |
GO:0007155 | cell adhesion | 6.47e-01 | 1.00e+00 | -0.130 | 2 | 3 | 384 |
GO:0043687 | post-translational protein modification | 6.47e-01 | 1.00e+00 | -0.045 | 1 | 1 | 181 |
GO:0005509 | calcium ion binding | 6.57e-01 | 1.00e+00 | -0.162 | 3 | 4 | 589 |
GO:0004930 | G-protein coupled receptor activity | 6.70e-01 | 1.00e+00 | -0.137 | 1 | 1 | 193 |
GO:0004872 | receptor activity | 6.82e-01 | 1.00e+00 | -0.181 | 1 | 1 | 199 |
GO:0045892 | negative regulation of transcription, DNA-templated | 7.00e-01 | 1.00e+00 | -0.273 | 2 | 2 | 424 |
GO:0005789 | endoplasmic reticulum membrane | 7.08e-01 | 1.00e+00 | -0.273 | 3 | 3 | 636 |
GO:0004871 | signal transducer activity | 7.11e-01 | 1.00e+00 | -0.300 | 1 | 1 | 216 |
GO:0008270 | zinc ion binding | 7.35e-01 | 1.00e+00 | -0.282 | 5 | 7 | 1067 |
GO:0008150 | biological_process | 7.41e-01 | 1.00e+00 | -0.387 | 2 | 3 | 459 |
GO:0007399 | nervous system development | 7.56e-01 | 1.00e+00 | -0.481 | 1 | 1 | 245 |
GO:0055114 | oxidation-reduction process | 7.64e-01 | 1.00e+00 | -0.455 | 2 | 2 | 481 |
GO:0042802 | identical protein binding | 7.74e-01 | 1.00e+00 | -0.484 | 2 | 4 | 491 |
GO:0000166 | nucleotide binding | 7.91e-01 | 1.00e+00 | -0.632 | 1 | 2 | 272 |
GO:0003779 | actin binding | 7.95e-01 | 1.00e+00 | -0.648 | 1 | 3 | 275 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 7.95e-01 | 1.00e+00 | -0.648 | 1 | 2 | 275 |
GO:0055085 | transmembrane transport | 7.96e-01 | 1.00e+00 | -0.550 | 2 | 3 | 514 |
GO:0030198 | extracellular matrix organization | 8.18e-01 | 1.00e+00 | -0.749 | 1 | 1 | 295 |
GO:0005743 | mitochondrial inner membrane | 8.23e-01 | 1.00e+00 | -0.774 | 1 | 1 | 300 |
GO:0007268 | synaptic transmission | 8.70e-01 | 1.00e+00 | -1.008 | 1 | 1 | 353 |
GO:0007186 | G-protein coupled receptor signaling pathway | 8.80e-01 | 1.00e+00 | -1.064 | 1 | 1 | 367 |
GO:0006508 | proteolysis | 9.07e-01 | 1.00e+00 | -1.224 | 1 | 2 | 410 |
GO:0009986 | cell surface | 9.13e-01 | 1.00e+00 | -1.266 | 1 | 1 | 422 |
GO:0003674 | molecular_function | 9.52e-01 | 1.00e+00 | -1.578 | 1 | 1 | 524 |
GO:0005615 | extracellular space | 9.81e-01 | 1.00e+00 | -1.525 | 2 | 3 | 1010 |
GO:0005887 | integral component of plasma membrane | 9.97e-01 | 1.00e+00 | -2.453 | 1 | 2 | 961 |
GO:0005576 | extracellular region | 9.98e-01 | 1.00e+00 | -2.580 | 1 | 4 | 1049 |
GO:0016021 | integral component of membrane | 1.00e+00 | 1.00e+00 | -2.238 | 3 | 4 | 2483 |